Document:

Registration Rights Agreement

 Exhibit 4.2 
 EXECUTION VERSION 
 KANSAS CITY SOUTHERN de MÉXICO, S.A. de C.V. 

U.S.$185,000,000 6.625% Senior Notes Due 2020 
 REGISTRATION RIGHTS AGREEMENT 
 December 20, 2010 

Merrill Lynch, Pierce, Fenner & Smith 
 Incorporated 
 J.P. Morgan Securities LLC 
 Scotia Capital (USA) Inc. 
 BBVA Securities Inc. 

Citigroup Global Markets Inc. 
 UBS Securities
LLC 
     as Placement Agents 
 c/o Merrill Lynch, Pierce, Fenner & Smith 
 Incorporated 

One Bryant Park New York, 
 New York 10036 
 Ladies and Gentlemen: 

Kansas City Southern de México, S.A. de C.V., a sociedad anónima de capital variable organized under the laws of the
United Mexican States (the “Company”), proposes to issue and sell to Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC, Scotia Capital (USA) Inc., BBVA Securities Inc., Citigroup Global Markets Inc.
and UBS Securities LLC (the “Placement Agents”), U.S.$185,000,000 principal amount of its 6.625% Senior Notes Due 2020 (the “Securities”), upon the terms set forth in the Placement Agreement between the Company and the Placement
Agents dated December 14, 2010 (the “Placement Agreement”) relating to the initial placement (the “Initial Placement”) of the Securities. To induce the Placement Agents to enter into the Placement Agreement and to satisfy a
condition to your obligations thereunder, the Company agrees with you for your benefit and the benefit of the holders from time to time of the Securities (including the Placement Agents) (each a “Holder” and, collectively, the
“Holders”), as follows: 
 1. Definitions. Capitalized terms used herein without definition shall have their
respective meanings set forth in the Placement Agreement. As used in this Agreement, the following capitalized defined terms shall have the following meanings: 
 “Act” shall mean the Securities Act of 1933, as amended, and the rules and regulations of the Commission promulgated thereunder. 

“Affiliate” shall have the meaning specified in Rule 405 under the Act and the terms “controlling” and
“controlled” shall have meanings correlative thereto. 

 “Broker-Dealer” shall mean any broker or dealer registered as such under the
Exchange Act. 
 “Business Day” shall mean any day other than a Saturday, a Sunday or a legal holiday or a day on
which banking institutions or trust companies are authorized or obligated by law to close in New York City. 
 “Closing
Date” shall mean the date of the first issuance of the Securities. 
 “Commission” shall mean the Securities and
Exchange Commission. 
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission promulgated thereunder. 
 “Exchange Offer Registration Period” shall mean the one-year
period following the consummation of the Registered Exchange Offer, exclusive of any period during which any stop order shall be in effect suspending the effectiveness of the Exchange Offer Registration Statement. 

“Exchange Offer Registration Statement” shall mean a registration statement of the Company on an appropriate form under the Act
with respect to the Registered Exchange Offer, all amendments and supplements to such registration statement, including post-effective amendments thereto, in each case including the Prospectus contained therein, all exhibits thereto and all material
incorporated by reference therein. 
 “Exchanging Dealer” shall mean any Holder (which may include the Placement
Agents) that is a Broker-Dealer and elects to exchange for New Securities any Securities that it acquired for its own account as a result of market-making activities or other trading activities (but not directly from the Company or any Affiliate of
the Company) for New Securities. 
 “Final Memorandum” shall mean the offering memorandum, dated December 14,
2010, relating to the Securities, including any and all exhibits and appendices thereto and any information incorporated by reference therein as of such date. 
 “FINRA Rules” shall mean the Conduct Rules and the By-Laws of the Financial Industry Regulatory Authority, Inc. 
 “Holder” shall have the meaning set forth in the preamble hereto. 

“Indenture” shall mean the Indenture relating to the Securities, dated as of December 20, 2010, among the Company, U.S.
Bank National Association, as trustee and paying agent, as the same may be amended from time to time in accordance with the terms thereof. 
 “Initial Placement” shall have the meaning set forth in the preamble. 

“Losses” shall have the meaning set forth in Section 6(d) hereof. 

  
 2 

 “Majority Holders” shall mean, on any date, Holders of a majority of the aggregate
principal amount of outstanding Securities registered under a Registration Statement. 
 “Managing Underwriters” shall
mean the investment bank or investment banks and manager or managers that administer an underwritten offering, if any, under a Registration Statement. 
 “New Securities” shall mean debt securities of the Company identical in all material respects to the Securities (except that the transfer restrictions shall be modified or eliminated, as
appropriate) to be issued under the New Securities Indenture. 
 “New Securities Indenture” shall mean an indenture
between the Company and the New Securities Trustee, identical in all material respects to the Indenture (except that the transfer restrictions shall be modified or eliminated, as appropriate), which may be the Indenture if in the terms thereof
appropriate provision is made for the New Securities. 
 “New Securities Trustee” shall mean a bank or trust company
reasonably satisfactory to the Placement Agents, as trustee with respect to the New Securities under the New Securities Indenture. 
 “Prospectus” shall mean the prospectus included in any Registration Statement (including, without limitation, a prospectus that discloses information previously omitted from a prospectus filed
as part of an effective registration statement in reliance upon Rule 430A under the Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Securities or the New Securities
covered by such Registration Statement, and all amendments and supplements thereto, including any and all exhibits thereto and any information incorporated by reference therein. 

“Registered Exchange Offer” shall mean the proposed offer of the Company to issue and deliver to the Holders of the Securities
that are not prohibited by any law or policy of the Commission from participating in such offer, in exchange for the Securities, a like aggregate principal amount of the New Securities. 

“Registrable Securities” shall mean (i) Securities other than those that have been (A) registered under a
Registration Statement and exchanged or otherwise disposed of in accordance therewith or (B) distributed to the public pursuant to Rule 144 under the Act or any successor rule or regulation thereto that may be adopted by the Commission and
(ii) any New Securities, the resale of which by the Holder thereof requires compliance with the prospectus delivery requirements of the Act. 
 “Registration Default Damages” shall have the meaning set forth in Section 8 hereof. 
 “Registration Statement” shall mean any Exchange Offer Registration Statement or Shelf Registration Statement that covers any of the Securities or the New Securities pursuant to the provisions
of this Agreement, any amendments and supplements to such registration statement, including post-effective amendments (in each case including the Prospectus contained therein), all exhibits thereto and all material incorporated by reference therein.

  
 3 

 “Securities” shall have the meaning set forth in the preamble hereto. 

“Shelf Registration” shall mean a registration effected pursuant to Section 3 hereof. 

“Shelf Registration Period” has the meaning set forth in Section 3(b)(ii) hereof. 

“Shelf Registration Statement” shall mean a “shelf” registration statement of the Company pursuant to the provisions
of Section 3 hereof which covers some or all of the Securities or New Securities, as applicable, on an appropriate form under Rule 415 under the Act, or any similar rule that may be adopted by the Commission, amendments and supplements to such
registration statement, including post-effective amendments, in each case including the Prospectus contained therein, all exhibits thereto and all material incorporated by reference therein. 

“Trustee” shall mean the trustee with respect to the Securities under the Indenture. 

“Trust Indenture Act” shall mean the Trust Indenture Act of 1939, as amended, and the rules and regulations of the Commission
promulgated thereunder. 
 “underwriter” shall mean any underwriter of Securities in connection with an offering
thereof under a Shelf Registration Statement. 
 2. Registered Exchange Offer. (a) To the extent not prohibited by
any applicable law or applicable interpretation of the staff of the Commission, the Company shall as promptly as practicable prepare and file with the Commission the Exchange Offer Registration Statement with respect to the Registered Exchange
Offer. The Company shall use its commercially reasonable efforts to cause the Exchange Offer Registration Statement to become effective under the Act and to complete the Registered Exchange Offer within 360 days of the Closing Date. 

(b) Upon the effectiveness of the Exchange Offer Registration Statement, the Company shall promptly commence the Registered Exchange
Offer, it being the objective of such Registered Exchange Offer to enable each Holder electing to exchange Securities for New Securities (assuming that such Holder is not an Affiliate of the Company, acquires the New Securities in the ordinary
course of such Holder’s business, has no arrangements with any person to participate in the distribution of the New Securities and is not prohibited by any law or policy of the Commission from participating in the Registered Exchange Offer) to
trade such New Securities from and after their receipt without any limitations or restrictions under the Act and without material restrictions under the securities laws of a substantial proportion of the several states of the United States.

 (c) In connection with the Registered Exchange Offer, the Company shall: 

(i) mail to each Holder a copy of the Prospectus forming part of the Exchange Offer Registration Statement, together with
an appropriate letter of transmittal and related documents; 
 (ii) keep the Registered Exchange Offer open for
not less than 20 Business Days and use its commercially reasonable efforts to keep the Registered Exchange Offer open for not more than 40 Business Days after the date notice thereof is mailed to the Holders (or, in each case, longer if required by
applicable law); 

  
 4 

 (iii) use its commercially reasonable efforts to keep the Exchange Offer
Registration Statement continuously effective under the Act, supplemented and amended as required, under the Act to ensure that it is available for sales of New Securities by Exchanging Dealers during the Exchange Offer Registration Period;

 (iv) utilize the services of a depositary for the Registered Exchange Offer with an address in the Borough of
Manhattan in New York City, which may be the Trustee, the New Securities Trustee or an Affiliate of either of them; 
 (v) permit Holders to withdraw tendered Securities (in accordance with the procedures set forth in the Exchange Offer Registration Statement) at any time prior to the close of business, New York time, on
the last Business Day on which the Registered Exchange Offer is open; 
 (vi) prior to effectiveness of the
Exchange Offer Registration Statement, provide a supplemental letter to the Commission (A) stating that the Company is conducting the Registered Exchange Offer in reliance on the position of the Commission in Exxon Capital Holdings Corporation
(pub. avail. May 13, 1988) and Morgan Stanley and Co., Inc. (pub. avail. June 5, 1991); and (B) including a representation that the Company has not entered into any arrangement or understanding with any person to distribute the New
Securities to be received in the Registered Exchange Offer and that, to the Company’s information and belief, each Holder participating in the Registered Exchange Offer is acquiring the New Securities in the ordinary course of business and has
no arrangement or understanding with any person to participate in the distribution of the New Securities; and 

(vii) comply in all material respects with all applicable laws. 

(d) As soon as practicable after the close of the Registered Exchange Offer, the Company shall: 

(i) accept for exchange all Securities tendered and not validly withdrawn pursuant to the Registered Exchange Offer;

 (ii) deliver or cause to be delivered to the Trustee for cancellation in accordance with Section 4(s) all
Securities so accepted for exchange; and 
 (iii) cause the New Securities Trustee promptly to authenticate and
deliver to each Holder of Securities a principal amount of New Securities equal to the principal amount of the Securities of such Holder so accepted for exchange. 
 (e) Each Holder hereby acknowledges and agrees that any Broker-Dealer and any such Holder using the Registered Exchange Offer to participate in a distribution of the New Securities (i) could not
under Commission policy as in effect on the date of this Agreement rely on the position of the Commission in Exxon Capital Holdings Corporation (pub. avail. May 13, 1988) 

  
 5 

 
and Morgan Stanley and Co., Inc. (pub. avail. June 5, 1991), as interpreted in the Commission’s letter to Shearman & Sterling dated July 2, 1993 and similar no-action
letters and (ii) must comply with the registration and prospectus delivery requirements of the Act in connection with any secondary resale transaction, which must be covered by an effective registration statement containing the selling security
holder information required by Item 507 or 508, as applicable, of Regulation S-K under the Act if the resales are of New Securities obtained by such Holder in exchange for Securities acquired by such Holder directly from the Company or one of
its Affiliates. Accordingly, each Holder participating in the Registered Exchange Offer shall be required to represent to the Company that: 
 (i) any New Securities to be received by such Holder will be acquired in the ordinary course of business; 
 (ii) at the time of the consummation of the Registered Exchange Offer, such Holder will have no arrangement or understanding with any person to participate in the distribution of the Securities or the New
Securities within the meaning of the Act; and 
 (iii) such Holder is not an Affiliate of the Company;

 and to make such other representations as may be necessary under applicable Commission rules, regulations or interpretations to render the
use of the Form S-4 or other appropriate form under the Act available. 
 (f) If, in the reasonable opinion of the Placement
Agents, a Placement Agent is not eligible to participate in the Registered Exchange Offer with respect to the exchange of Securities constituting any portion of an unsold allotment, at the request of the Placement Agents, the Company shall issue and
deliver to the Placement Agents or the person purchasing New Securities registered under a Shelf Registration Statement as contemplated by Section 3 hereof from the Placement Agents, in exchange for such Securities, a like principal amount of
New Securities. The Company shall use its commercially reasonable efforts to cause the CUSIP Service Bureau to issue the same CUSIP number for such New Securities as for New Securities issued pursuant to the Registered Exchange Offer. 

3. Shelf Registration. (a) If (i) due to any change in law or applicable interpretations thereof by the
Commission’s staff, the Company determines upon advice of its outside counsel that it is not permitted to effect the Registered Exchange Offer as contemplated by Section 2 hereof; (ii) for any other reason the Registered Exchange
Offer is not consummated within 360 days of the date hereof; (iii) any Holder (other than the Placement Agents) is not eligible to participate in the Registered Exchange Offer other than by reason of such Holder being an Affiliate of the
Company; (iv) based on their reasonable opinion, the Placement Agents so requests with respect to Securities that are not eligible to be exchanged for New Securities in the Registered Exchange Offer that are held by them following consummation
of the Registered Exchange Offer, such request being in writing and delivered to the Company; or (v) in the case that the Placement Agents participate in the Registered Exchange Offer or acquire New Securities pursuant to Section 2(f)
hereof, in their reasonable opinion the Placement Agents do not receive freely tradeable New Securities in exchange for Securities constituting any portion of an unsold allotment (it being understood that (A) the requirement that the Placement
Agents 

  
 6 

 
deliver a Prospectus containing the information required by Item 507 or 508 of Regulation S-K under the Act in connection with sales of New Securities acquired in exchange for such
Securities shall result in such New Securities being not “freely tradeable” and (B) the requirement that an Exchanging Dealer deliver a Prospectus in connection with sales of New Securities acquired in the Registered Exchange Offer in
exchange for Securities acquired as a result of market-making activities or other trading activities shall not result in such New Securities being not “freely tradeable”), the Company shall effect a Shelf Registration Statement in
accordance with subsection (b) below. 
 (b) (i) The Company shall as promptly as practicable file with the Commission and
shall use its commercially reasonable efforts to cause to be declared effective under the Act within 360 days after the Closing Date, a Shelf Registration Statement relating to the offer and sale of the Securities or the New Securities, as
applicable, by the Holders thereof from time to time in accordance with the methods of distribution elected by such Holders and set forth in such Shelf Registration Statement; provided, however, that no Holder (other than the Placement Agents) shall
be entitled to have the Securities held by it covered by such Shelf Registration Statement unless such Holder agrees in writing to be bound by all of the provisions of this Agreement applicable to such Holder (it being understood that Holders who
would have received freely transferable Securities pursuant to the Registered Exchange Offer had they not (A) failed to duly tender their Securities for exchange pursuant to the Registered Exchange Offer (other than the Placement Agents in
connection with Securities held by them constituting any portion of an unsold allotment), or otherwise failed to comply with the requirements of the Registered Exchange Offer as provided in Section 2 hereof or (B) failed to furnish to the
Company such information as the Company may request in accordance with Section 4(o) in connection with a Shelf Registration Statement, shall not retain any rights under this Agreement, including any right to have Securities owned by them
included in any Shelf Registration Statement); and provided further that, with respect to New Securities received by the Placement Agents in exchange for Securities constituting any portion of an unsold allotment, the Company may, if permitted by
current interpretations by the Commission’s staff, file a post-effective amendment to the Exchange Offer Registration Statement containing the information required by Item 507 or 508 of Regulation S-K of the Act, as applicable, in
satisfaction of its obligations under this subsection with respect thereto, and any such Exchange Offer Registration Statement, as so amended, shall be referred to herein as, and governed by the provisions herein applicable to, a Shelf Registration
Statement. 
 (ii) The Company shall, except as permitted under Section 4(k)(ii), keep the Shelf Registration Statement
continuously effective, supplemented and amended as required by the Act, in order to permit the Prospectus forming part thereof to be usable by Holders for a period (the “Shelf Registration Period”) from the date the Shelf Registration
Statement is declared effective by the Commission until (A) the first anniversary thereof or (B) the earlier date upon which all the Securities or New Securities, as applicable, covered by the Shelf Registration Statement have been sold
pursuant to the Shelf Registration Statement. 
 (iii) The Company shall cause the Shelf Registration Statement and the related
Prospectus and any amendment or supplement thereto, as of the effective date of the Shelf Registration Statement or such amendment or supplement, (A) to comply in all material respects with the applicable requirements of the Act; and
(B) not to contain any untrue statement of a 

  
 7 

 
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein (in the case of the Prospectus, in the light of the circumstances
under which they were made) not misleading. 
 4. Additional Registration Procedures. In connection with any Shelf
Registration Statement and, to the extent applicable, any Exchange Offer Registration Statement, the following provisions shall apply. 
 (a) The Company shall: 
 (i) furnish to the Placement Agents and to
counsel for the Majority Holders, not less than five Business Days prior to the filing thereof with the Commission, a copy of any Exchange Offer Registration Statement and any Shelf Registration Statement, and each amendment thereof and each
amendment or supplement, if any, to the Prospectus included therein (including all documents incorporated by reference therein after the initial filing) and shall use its commercially reasonable efforts to reflect in each such document, when so
filed with the Commission, such comments as the Placement Agents may reasonably propose; 
 (ii) include the
information set forth in Annex A hereto on the facing page of the Exchange Offer Registration Statement, in Annex B hereto in the forepart of the Exchange Offer Registration Statement in a section setting forth details of the Exchange Offer, in
Annex C hereto in the underwriting or plan of distribution section of the Prospectus contained in the Exchange Offer Registration Statement, and in Annex D hereto in the letter of transmittal delivered pursuant to the Registered Exchange Offer;

 (iii) if requested by the Placement Agents, include the information required by Item 507 or 508 of
Regulation S-K, as applicable, in the Prospectus contained in the Exchange Offer Registration Statement; and 

(iv) in the case of a Shelf Registration Statement, include the names of the Holders that propose to sell Securities
pursuant to the Shelf Registration Statement as selling security holders. 
 (b) The Company shall ensure that: 

(i) any Registration Statement and any amendment thereto and any Prospectus forming part thereof and any amendment or
supplement thereto complies in all material respects with the Act; and 
 (ii) any Registration Statement and any
amendment thereto does not, when it becomes effective, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. 

(c) The Company shall advise the Placement Agents, the Holders of Securities covered by any Shelf Registration Statement and any
Exchanging Dealer under any Exchange Offer Registration Statement that has provided in writing to the Company a telephone or facsimile 

  
 8 

 
number and address for notices, and, if requested by any Placement Agent or any such Holder or Exchanging Dealer, shall confirm such advice in writing (which notice pursuant to clauses
(ii)-(v) hereof shall be accompanied by an instruction to suspend the use of the Prospectus until the Company shall have remedied the basis for such suspension): 

(i) when a Registration Statement and any amendment thereto has been filed with the Commission and when the Registration
Statement or any post-effective amendment thereto has become effective; 
 (ii) of any request by the Commission
for any amendment or supplement to the Registration Statement or the Prospectus or for additional information; 

(iii) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or
the institution or threatening of any proceeding for that purpose; 
 (iv) of the receipt by the Company of any
notification with respect to the suspension of the qualification of the securities included therein for sale in any jurisdiction or the institution or threatening of any proceeding for such purpose; and 

(v) of the happening of any event that requires any change in the Registration Statement or the Prospectus so that, as of
such date, they (A) do not contain any untrue statement of a material fact and (B) do not omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of the Prospectus, in the light
of the circumstances under which they were made) not misleading. 
 (d) The Company shall use its commercially reasonable
efforts to prevent the issuance of any order suspending the effectiveness of any Registration Statement or the qualification of the securities therein for sale in any jurisdiction and, if issued, to obtain as soon as possible the withdrawal thereof.

 (e) The Company shall furnish to each Holder of Securities covered by any Shelf Registration Statement, without charge, at
least one copy of such Shelf Registration Statement and any post-effective amendment thereto, including all material incorporated therein by reference, and, if the Holder so requests in writing, all exhibits thereto (including exhibits incorporated
by reference therein). 
 (f) The Company shall, during the Shelf Registration Period, deliver to each Holder of Securities
covered by any Shelf Registration Statement, without charge, as many copies of the Prospectus (including the Preliminary Prospectus) included in such Shelf Registration Statement and any amendment or supplement thereto as such Holder may reasonably
request. The Company consents to the use of the Prospectus or any amendment or supplement thereto by each of the selling Holders of Securities in connection with the offering and sale of the Securities covered by the Prospectus, or any amendment or
supplement thereto, included in the Shelf Registration Statement. 
 (g) The Company shall furnish to each Exchanging Dealer
which so requests, without charge, at least one copy of the Exchange Offer Registration Statement and any post-effective 

  
 9 

 
amendment thereto, including all material incorporated by reference therein, and, if the Exchanging Dealer so requests in writing, all exhibits thereto (including exhibits incorporated by
reference therein). 
 (h) The Company shall promptly deliver to the Placement Agents, each Exchanging Dealer and each other
person required to deliver a Prospectus during the Exchange Offer Registration Period, without charge, as many copies of the Prospectus included in such Exchange Offer Registration Statement and any amendment or supplement thereto as any such person
may reasonably request. The Company consents to the use of the Prospectus or any amendment or supplement thereto by the Placement Agents, any Exchanging Dealer and any such other person that may be required to deliver a Prospectus following the
Registered Exchange Offer in connection with the offering and sale of the New Securities covered by the Prospectus, or any amendment or supplement thereto, included in the Exchange Offer Registration Statement. 

(i) Prior to the Registered Exchange Offer or any other offering of Securities pursuant to any Registration Statement, the Company shall
arrange, if necessary, for the qualification of the Securities or the New Securities for sale under the laws of such jurisdictions as any Holder shall reasonably request and shall maintain such qualification in effect so long as required; provided
that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not then so qualified or to take any action that would subject it to service of process in suits in any such jurisdiction where it is not then
so subject. 
 (j) The Company shall cooperate with the Holders to facilitate the timely preparation and delivery of
certificates representing New Securities or Securities to be issued or sold pursuant to any Registration Statement free of any restrictive legends and in such denominations and registered in such names as Holders may request at least two Business
Days prior to such sale of Securities or New Securities. 
 (k) (i) Upon the occurrence of any event contemplated by subsections
(c)(ii) through (v) above, the Company shall promptly prepare a post-effective amendment to the applicable Registration Statement or an amendment or supplement to the related Prospectus or file any other required document so that, as thereafter
delivered, the Prospectus will not include an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading. In such circumstances, the period of effectiveness of the Exchange Offer Registration Statement provided for in Section 2 shall be extended by the number of days from and including the date of the giving of a notice of
suspension pursuant to Section 4(c) to and including the date when the Placement Agents, the Holders of the Securities and any known Exchanging Dealer shall have received such amended or supplemented Prospectus pursuant to this Section.

 (ii) Upon the happening of any event of the kind described in subsection (c)(v) hereof, or the determination
by the Company that, in its reasonable judgment and upon written advice of counsel, the continued effectiveness and use of the Shelf Registration Statement would require the disclosure of confidential information or interfere with any financing,
acquisition, reorganization or other material transaction involving the Company, such Holder will forthwith discontinue disposition of Securities or New 

  
 10 

 
Securities pursuant to a Registration Statement until such Holder’s receipt of the copies of the supplemented or amended Prospectus contemplated by subsection (f) hereof (or a notice
from the Company that such Holder may resume use of the existing Prospectus), and, if so directed by the Company, such Holder will deliver to the Company (at the Company’s expense) all copies in its possession, other than permanent file copies
then in such Holder’s possession, of the Prospectus covering such Securities current at the time of receipt of such notice. If the Company shall give any such notice to suspend the disposition of Securities pursuant to a Registration Statement,
the Company shall extend the period during which the Registration Statement shall be maintained effective pursuant to this Agreement by the number of days during the period from and including the date of the giving of such notice to and including
the date when the Holders shall have (A) received copies of the supplemented or amended Prospectus necessary to resume such dispositions or (B) a notice permitting use of the existing Prospectus. The Company may give any such notice only
twice during any 365-day period and any such suspensions may not exceed 30 days for each suspension and there may not be more than two suspensions in effect during any 365-day period. 

(l) Not later than the effective date of any Registration Statement, the Company shall provide a CUSIP number for the Securities or the
New Securities, as the case may be, registered under such Registration Statement and provide the Trustee with printed certificates for such Securities or New Securities, in a form eligible for deposit with The Depository Trust Company. 

(m) The Company shall comply in all material respects with all applicable rules and regulations of the Commission and shall make
generally available to its security holders an earnings statement satisfying the provisions of Section 11(a) of the Act as soon as practicable after the effective date of the applicable Registration Statement and in any event no later than 90
days after the end of a 12-month period (or 180 days, if such period is a fiscal year) beginning with the first month of the Company’s first fiscal quarter commencing after the effective date of the applicable Registration Statement.

 (n) The Company shall cause the New Securities Indenture to be qualified under the Trust Indenture Act in a timely manner.

 (o) The Company may require each Holder of Securities to be sold pursuant to any Shelf Registration Statement to furnish to
the Company such information regarding the Holder and the distribution of such securities as the Company may from time to time reasonably require for inclusion in such Registration Statement. The Company may exclude from such Shelf Registration
Statement the Securities of any Holder that fails to furnish such information within a reasonable time after receiving such request. 
 (p) In the case of any Shelf Registration Statement, the Company shall enter into customary agreements (including, if requested, an underwriting agreement in customary form) and take all other appropriate
actions in order to expedite or facilitate the registration or the disposition of the Securities, and in connection therewith, if an underwriting agreement is entered into, cause the same to contain indemnification provisions and procedures no less
favorable than those set forth in Section 6 hereof. 

  
 11 

 (q) In the case of any Shelf Registration Statement, the Company shall: 

(i) make reasonably available for inspection by the Holders of Securities to be registered thereunder, any underwriter
participating in any disposition pursuant to such Registration Statement, and any attorney, accountant or other agent retained by the Holders or any such underwriter all relevant financial and other records and pertinent corporate documents of the
Company and its subsidiaries; provided, however, that, if any such records, documents or other information are related to pending or proposed acquisitions or dispositions, or otherwise related to matters reasonably considered by the Company to
constitute sensitive or proprietary information, the Company need not provide such records, documents or information unless the foregoing parties enter into a confidentiality agreement in customary form and reasonably acceptable to such parties and
the Company; 
 (ii) cause the Company’s officers, directors, employees, accountants and auditors to supply
all relevant information reasonably requested by the Holders or any such underwriter, legal counsel, accountant or agent in connection with any such Registration Statement as is customary for similar due diligence examinations; provided, however,
that such information may not be used for any other purpose than due diligence and provided further, however, that any information that is designated in writing by the Company, in good faith, as confidential at the time of delivery of such
information shall be kept confidential by the Holders or any such underwriter, legal counsel, accountant or agent, unless such disclosure is made in connection with a court proceeding or required by law, or such information becomes available to the
public generally or through a third party without an accompanying obligation of confidentiality; 
 (iii) make
such representations and warranties to the Holders of Securities registered thereunder and the underwriters, if any, in form, substance and scope as are customarily made by issuers to underwriters in primary underwritten offerings and covering
matters including, but not limited to, those set forth in the Placement Agreement; 
 (iv) obtain opinions of
counsel to the Company and updates thereof (which counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the Managing Underwriters, if any) addressed to each selling Holder and the underwriters, if any, covering such
matters as are customarily covered in opinions requested in underwritten offerings and such other matters as may be reasonably requested by such Holders and underwriters; 

(v) obtain comfort letters and updates thereof from the independent certified public accountants of the Company (and, if
necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by the Company for which financial statements and financial data are, or are required to be, included in the Registration
Statement), addressed to each selling Holder of Securities registered thereunder and the underwriters, if any, provided that such letters need not be addressed to any Holder to whom, in the reasonable opinion of the Company’s independent public
accountants, addressing such letter is not permissible under applicable accounting standards, in customary form and covering matters of the type customarily covered in comfort letters in connection with primary underwritten offerings; 

  
 12 

 (vi) deliver such documents and certificates as may be reasonably requested
by the Majority Holders or the Managing Underwriters, if any, including those to evidence compliance with Section 4(k) and with any customary conditions contained in the underwriting agreement or other agreement entered into by the Company; and

 (vii) if reasonably requested by any Holder of Registrable Securities covered by a Registration Statement,
(A) promptly incorporate in a Prospectus supplement or post-effective amendment such information with respect to such Holder as such Holder reasonably requests to be included therein and (B) make all required filings of such Prospectus
supplement or such post-effective amendment as soon as the Company has received notification of the matters to be incorporated in such filing. 

The actions set forth in clauses (iii), (iv), (v) and (vi) of this paragraph (q) shall be performed at (i) the effectiveness of such
Registration Statement and each post-effective amendment thereto and (ii) each closing under any underwriting or similar agreement as and to the extent required thereunder. 

(r) In the case of any Exchange Offer Registration Statement, the Company shall: 

(i) make reasonably available for inspection by the Placement Agents, and any legal counsel, accountant or other agent
retained by the Placement Agents, all relevant financial and other records, pertinent corporate documents and properties of the Company and its subsidiaries; provided, however, that, if any such records, documents or other information related to
pending or proposed acquisitions or dispositions, or otherwise related to matters reasonably acceptable to such parties and the Company to constitute sensitive or proprietary information, the Company need not provide such records, documents or
information unless the foregoing parties enter into a confidentiality agreement in customary form and reasonably acceptable to such parties and the Company; 
 (ii) cause the Company’s officers, directors, employees, accountants and auditors to supply all relevant information reasonably requested by the Placement Agents or any such attorney, accountant or
agent in connection with any such Registration Statement as is customary for similar due diligence examinations; provided, however, that such information may not be used for any purpose other than due diligence and provided, further, however, that
any information that is designated in writing by the Company, in good faith, as confidential at the time of delivery of such information shall be kept confidential by the Placement Agents or any such attorney, accountant or agent, unless such
disclosure is made in connection with a court proceeding or required by law, or such information becomes available to the public through a third party without an accompanying obligation of confidentiality; 

(iii) make such representations and warranties to the Placement Agents, in form, substance and scope as are customarily
made by issuers to underwriters in primary underwritten offerings and covering matters including, but not limited to, those set forth in the Placement Agreement; 

  
 13 

 (iv) obtain opinions of counsel to the Company and updates thereof (which
counsel and opinions (in form, scope and substance) shall be reasonably satisfactory to the Placement Agents and their counsel, addressed to the Placement Agents, covering such matters as are customarily covered in opinions requested in underwritten
offerings and such other matters as may be reasonably requested by the Placement Agents or their counsel; 
 (v)
obtain comfort letters and updates thereof from the independent certified public accountants of the Company (and, if necessary, any other independent certified public accountants of any subsidiary of the Company or of any business acquired by the
Company for which financial statements and financial data are, or are required to be, included in the Registration Statement), addressed to the Placement Agents, in customary form and covering matters of the type customarily covered in comfort
letters in connection with primary underwritten offerings, or if requested by the Placement Agents or their counsel in lieu of a comfort letter, an agreed-upon procedures letter under Statement on Auditing Standards No. 35, covering matters
requested by the Placement Agents or their counsel; and 
 (vi) deliver such documents and certificates as may be
reasonably requested by the Placement Agents or their counsel, including those to evidence compliance with Section 4(k) and with conditions customarily contained in underwriting agreements; 

provided, however that the Company will be required to perform the foregoing actions set forth in clauses (i) through (vi) only
upon the reasonable request by the Placement Agents to the Company or the reasonable request in writing to the Company by one or more broker-dealers who certify to the Placement Agents and the Company in writing that they anticipate they will
receive New Securities for their own account in the Exchange Offer for Securities that were acquired by such broker-dealer as a result of market-making or other trading activities, and, based on the position of the Commission as described in
Section 2(e), will be required to satisfy the prospectus delivery obligation under the Act in connection with the resale of such New Securities; and provided further, that the Company will not be required to amend or supplement the Prospectus
contained in the Exchange Offer Registration Statement for a period exceeding the Exchange Offer Registration Period, and such broker-dealers shall not be authorized by the Company to deliver and shall not deliver such Prospectus after such period
in connection with resales contemplated in this subsection (r); and provided, further, that the Company will be obligated to deal only with one entity representing such broker-dealers, which shall be Merrill Lynch, Pierce, Fenner & Smith
Incorporated, unless it elects not to act as such representative, and to pay the reasonable fees and expenses of only one counsel representing such broker-dealers, which shall be the counsel to the Placement Agents, unless such counsel elects not to
so act, and to cause to be delivered only one, if any, comfort letter with respect to the Prospectus in the form existing on the expiration of the Exchange Offer and with respect to each subsequent amendment or supplement, if any, effected during
the period specified above. 

  
 14 

 The foregoing actions set forth in clauses (iii), (iv), (v) and (vi) of this
Section shall be performed at the close of the Registered Exchange Offer and the effective date of any post-effective amendment to the Exchange Offer Registration Statement. 
 (s) If a Registered Exchange Offer is to be consummated, upon delivery of the Securities by Holders to the Company (or to such other person as directed by the Company) in exchange for the New Securities,
the Company shall mark, or cause to be marked, on the Securities so exchanged that such Securities are being cancelled in exchange for the New Securities. In no event shall the Securities be marked as paid or otherwise satisfied. 

(t) The Company shall use its commercially reasonable efforts to confirm that the ratings issued to the Securities prior to their initial
sale will apply to the Securities or the New Securities, as the case may be, covered by a Registration Statement. 
 (u) In the
event that any Broker-Dealer shall underwrite any Securities or participate as a member of an underwriting syndicate or selling group or “assist in the distribution” (within the meaning of the FINRA Rules) thereof, whether as a Holder of
such Securities or as an underwriter, a placement or sales agent or a broker or dealer in respect thereof, or otherwise, the Company shall assist such Broker-Dealer in complying with the FINRA Rules. 

(v) The Company shall use its commercially reasonable efforts to take all other steps necessary to effect the registration of the
Securities or the New Securities, as the case may be, covered by a Registration Statement. 
 5. Registration Expenses.
The Company shall bear all expenses incurred in connection with the performance of its obligations under Sections 2, 3 and 4 hereof and, in the event of any Shelf Registration Statement, will reimburse the Holders for the reasonable fees and
disbursements of one firm or counsel (which shall initially be Shearman & Sterling LLP, but which may, with the written consent of the Placement Agents, be another nationally recognized law firm experienced in securities matters designated
by the Majority Holders) to act as counsel for the Holders in connection therewith, and, in the case of any Exchange Offer Registration Statement, will reimburse the Placement Agents for the reasonable fees and disbursements of counsel acting in
connection therewith. Each Holder shall pay all underwriting discounts and commissions and transfer taxes, if any, relating to the sale or disposition of such Holder’s Securities pursuant to the Shelf Registration Statement. 

6. Indemnification and Contribution. (a) The Company agrees to indemnify and hold harmless each Holder of Securities or New
Securities, as the case may be, covered by any Registration Statement, the Placement Agents and, with respect to any Prospectus delivery as contemplated in Section 4(h) hereof, each Exchanging Dealer, the directors, officers, employees and
agents of each such Holder, the Placement Agents or Exchanging Dealer and each person who controls any such Holder, the Placement Agents or Exchanging Dealer within the meaning of either the Act or the Exchange Act against any and all losses,
claims, damages or liabilities, joint or several, to which they or any of them may become subject under the Act, the Exchange Act or other federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims,
damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material fact contained in the 

  
 15 

 
Registration Statement as originally filed or in any amendment thereof, including all documents incorporated by reference therein or in any preliminary Prospectus or the Prospectus, or in any
amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of any preliminary
Prospectus or the Prospectus, in the light of the circumstances under which they were made) not misleading, and agrees to reimburse each such indemnified party, as incurred, for any legal or other expenses reasonably incurred by them in connection
with investigating or defending any such loss, claim, damage, liability or action; provided, however, that the Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon
any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or on behalf of the party claiming indemnification
specifically for inclusion therein; provided further, however, that with respect to any untrue statement or omission of a material fact made in any preliminary Prospectus, the indemnity agreement contained in this Section shall not inure to the
benefit of any Holder from whom the person asserting any such loss, claim, damage or liability purchased the Securities or New Securities, as the case may be, to the extent that any such loss, claim, damage or liability of such Holder occurs under
the circumstance where it shall have been determined by a court of competent jurisdiction by final and nonappealable judgment that (i) the untrue statement or omission of a material fact contained in the preliminary Prospectus was corrected in
the Prospectus, (ii) the Company had previously furnished copies of the Prospectus to such Holder prior to the written confirmation of the sale of such Securities or New Securities and (iii) such loss, claim, damage or liability results
from the fact that there was not sent or given to such person at or prior to the written confirmation of the sale of such Securities or New Securities, as the case may be, to such person, a copy of the Prospectus; and provided further, however, that
the Company shall not be liable to an indemnified party with respect to any Prospectus or Registration Statement or any amendment or supplement thereof to the extent that any such loss, claim, damage, liability or action of such indemnified party
arises out of, or is based upon, (i) the use of any Registration Statement during a period when a stop order has been issued by the Commission in respect thereof or (ii) the use of the Prospectus during a period when the use of the
Prospectus has been suspended in accordance with the instructions of the Company because of the discovery of any untrue statement or omission of a material fact therein, provided that all Holders of Securities or New Securities received prior
written notice of such stop order or suspension and such indemnified party, knowingly and voluntarily continued to use such Prospectus or Registration Statement. This indemnity agreement shall be in addition to any liability which the Company may
otherwise have. 
 The Company also agrees to indemnify as provided in this Section 6(a) or contribute as provided in
Section 6(d) hereof to Losses of each underwriter, if any, of Securities or New Securities, as the case may be, registered under a Shelf Registration Statement, their directors, officers, employees or agents and each person who controls such
underwriter on substantially the same basis as that of the indemnification of the Placement Agents and the selling Holders provided in this Section 6(a) and shall, if requested by any Holder, enter into an underwriting agreement reflecting such
agreement, as provided in Section 4(p) hereof. 
 (b) Each Holder of securities covered by a Registration Statement
(including the Placement Agents, but only if such Placement Agent is a Holder, in such capacity) severally and 

  
 16 

 
not jointly agrees to indemnify and hold harmless the Company, each of its directors, each of its officers who signs such Registration Statement and each person who controls the Company within
the meaning of either the Act or the Exchange Act, to the same extent as the foregoing indemnity from the Company to each such Holder, but only with reference to written information relating to such Holder furnished to the Company by or on behalf of
such Holder specifically for inclusion in the documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability which any such Holder may otherwise have. 

(c) Promptly after receipt by an indemnified party under this Section 6 or notice of the commencement of any action, such
indemnified party will, if a claim in respect thereof is to be made against the indemnifying party under this Section, notify the indemnifying party in writing of the commencement thereof; but the failure so to notify the indemnifying party
(i) will not relieve it from liability under paragraph (a) or (b) above unless and to the extent it did not otherwise learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and
defenses and (ii) will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation provided in paragraph (a) or (b) above. The indemnifying party shall be
entitled to appoint counsel (including local counsel) of the indemnifying party’s choice at the indemnifying party’s expense to represent the indemnified party in any action for which indemnification is sought (in which case the
indemnifying party shall not thereafter be responsible for the fees and expenses of any separate counsel, other than local counsel if not appointed by the indemnifying party, retained by the indemnified party or parties except as set forth below);
provided, however, that such counsel shall be reasonably satisfactory to the indemnified party. Notwithstanding the indemnifying party’s election to appoint counsel (including local counsel) to represent the indemnified party in an action, the
indemnified party shall have the right to employ separate counsel (including local counsel), and the indemnifying party shall bear the reasonable fees, costs and expenses of such separate counsel if (i) the use of counsel chosen by the
indemnifying party to represent the indemnified party would present such counsel with a conflict of interest; (ii) the actual or potential defendants in, or targets of, any such action include both the indemnified party and the indemnifying
party and the indemnified party shall have reasonably concluded that there may be legal defenses available to it and/or other indemnified parties which are different from or additional to those available to the indemnifying party; (iii) the
indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of the institution of such action; or (iv) the indemnifying party shall
authorize the indemnified party to employ separate counsel at the expense of the indemnifying party. An indemnifying party will not, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any
judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or
action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all liability arising out of such claim, action, suit or proceeding. 

(d) In the event that the indemnity provided in paragraph (a) or (b) of this Section is unavailable to or insufficient to hold
harmless an indemnified party for any reason, then each applicable indemnifying party shall have a joint and several obligation to contribute to the aggregate losses, claims, damages and liabilities (including legal or other expenses reasonably

  
 17 

 
incurred in connection with investigating or defending same) (collectively “Losses”) to which such indemnified party may be subject in such proportion as is appropriate to reflect the
relative benefits received by such indemnifying party, on the one hand, and such indemnified party, on the other hand, from the Initial Placement and the Registration Statement which resulted in such Losses; provided, however, that in no case shall
the Placement Agents be responsible, in the aggregate, for any amount in excess of the purchase discount or commission applicable to such Security, or in the case of a New Security, applicable to the Security that was exchangeable into such New
Security, nor shall any Holder be responsible, in the aggregate for any amount in excess of the amount by which the total price at which Registrable Securities were sold by such Holder exceeds the amount of any damages that such Holder has otherwise
been required to pay by reason of any untrue or alleged untrue statement or omission or alleged omission which resulted in such Losses, nor shall any underwriter be responsible for any amount in excess of the underwriting discount or commission
applicable to the securities purchased by such underwriter under the Registration Statement which resulted in such Losses. If the allocation provided by the immediately preceding sentence is unavailable for any reason, the indemnifying party and the
indemnified party shall contribute in such proportion as is appropriate to reflect not only such relative benefits but also the relative fault of such indemnifying party, on the one hand, and such indemnified party, on the other hand, in connection
with the statements or omissions which resulted in such Losses as well as any other relevant equitable considerations. Benefits received by the Company shall be deemed to be equal to the sum of (i) the total net proceeds from the Initial
Placement (before deducting expenses) as set forth on the cover page of the Final Memorandum and (ii) the total amount of additional interest which the Company was not required to pay as a result of registering the securities covered by the
Registration Statement which resulted in such Losses. Benefits received by the Placement Agents shall be deemed to be equal to the total purchase discounts and commissions less any expenses reimbursed pursuant to Section 6(f) of the Placement
Agreement, and benefits received by any other Holders shall be deemed to be equal to the value of receiving Securities or New Securities, as applicable, registered under the Act. Benefits received by any underwriter shall be deemed to be equal to
the total underwriting discounts and commissions, as set forth on the cover page of the Prospectus forming a part of the Registration Statement which resulted in such Losses. Relative fault shall be determined by reference to, among other things,
whether any untrue or any alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information provided by the indemnifying party, on the one hand, or by the indemnified party, on the other
hand, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The parties agree that it would not be just and equitable if contribution were determined by
pro rata allocation (even if the Holders were treated as one entity for such purpose) or any other method of allocation which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this
Section 6, in no event shall a Holder be required to contribute any amount in excess of the amount by which the total price at which the Securities or New Securities sold by such Holder exceeds the amount of any damages that such Holder has
otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. Furthermore, notwithstanding the provisions of this paragraph (d), no person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section, each person who controls a Holder within the meaning of either the Act

  
 18 

 
or the Exchange Act and each director, officer, employee and agent of such Holder shall have the same rights to contribution as such Holder, and each person who controls the Company within the
meaning of either the Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company shall have the same rights to contribution as the Company, subject in each case to the
applicable terms and conditions of this paragraph (d). 
 (e) The provisions of this Section will remain in full force and
effect, regardless of any investigation made by or on behalf of any Holder or the Company or any of the officers, directors or controlling persons referred to in this Section hereof, and will survive the sale by a Holder of securities covered by a
Registration Statement. 
 7. Underwritten Registrations. (a) If any of the Securities or New Securities, as the
case may be, covered by any Shelf Registration Statement are to be sold in an underwritten offering, the Managing Underwriters shall be selected by the Majority Holders. 
 (b) No person may participate in any underwritten offering pursuant to any Shelf Registration Statement, unless such person (i) agrees to sell such person’s Securities or New Securities, as the
case may be, on the basis reasonably provided in any underwriting arrangements approved by the persons entitled hereunder to approve such arrangements and (ii) completes and executes all questionnaires, powers of attorney, indemnities,
underwriting agreements and other documents reasonably required under the terms of such underwriting arrangements. 
 8.
Registration Defaults. If any of the following events shall occur, then the Company shall pay liquidated damages (the “Registration Default Damages”) to the Holders of Securities in respect of the Securities as follows: 

(a) if on or prior to the 360th day of following the Closing Date, neither the Registered Exchange Offer has been
completed nor the Shelf Registration Statement has been declared effective, then Registration Default Damages shall accrue on the Registrable Securities at a rate of .25% per annum and shall be payable in accordance with the interest payment
provisions of the Securities; or 
 (b) if any Registration Statement required by this Agreement has been
declared effective but ceases to be effective at any time at which it is required to be effective under this Agreement, then commencing on the day the Registration Statement ceases to be effective, Registration Default Damages shall accrue on the
Registrable Securities at a rate of 0.25% per annum and shall be payable in accordance with the interest payment provisions of the Securities; 
 provided, however, that (i) upon completion of the Registered Exchange Offer or the effectiveness of the Shelf Registration Statement (in the case of paragraph (a) above), or (ii) upon the
effectiveness of the Registration Statement which had ceased to remain effective (in the case of paragraph (b) above), Registration Default Damages shall cease to accrue. 

  
 19 

 9. No Inconsistent Agreements. The Company has not entered into, and agrees not to
enter into, any agreement with respect to its securities that is inconsistent with the rights granted to the Holders herein or that otherwise conflicts with the provisions hereof. 

10. Amendments and Waivers. The provisions of this Agreement may not be amended, qualified, modified or supplemented, and waivers
or consents to departures from the provisions hereof may not be given, unless the Company has obtained the written consent of the Holders of a majority of the aggregate principal amount of the Registrable Securities outstanding; provided that, with
respect to any matter that directly or indirectly affects the rights of the Placement Agents hereunder, the Company shall obtain the written consent of the Placement Agents against which such amendment, qualification, supplement, waiver or consent
is to be effective; provided, further, that no amendment, qualification, supplement, waiver or consent with respect to Section 8 hereof shall be effective as against any Holder of Registered Securities unless consented to in writing by such
Holder; and provided further that the provisions of this Section 10 may not be amended, qualified, modified or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the Company has obtained the
written consent of the Placement Agents and each Holder. Notwithstanding the foregoing (except the foregoing provisos), a waiver or consent to departure from the provisions hereof with respect to a matter that relates exclusively to the rights of
Holders whose Securities or New Securities, as the case may be, are being sold pursuant to a Registration Statement and that does not directly or indirectly affect the rights of other Holders may be given by the Majority Holders, determined on the
basis of Securities or New Securities, as the case may be, being sold rather than registered under such Registration Statement. 

11. Notices. All notices and other communications provided for or permitted hereunder shall be made in writing by hand-delivery,
first-class mail, telex, telecopier or air courier guaranteeing overnight delivery: 
 (a) if to a Holder, at the
most current address given by such holder to the Company in accordance with the provisions of this Section 11, which address initially is, with respect to each Holder, the address of such Holder maintained by the Registrar under the Indenture;

 (b) if to the Placement Agents, initially at the address or addresses set forth in the Placement Agreement;
and 
 (c) if to the Company, initially at its address set forth in the Placement Agreement. 

All such notices and communications shall be deemed to have been duly given when received. 

The Placement Agents or the Company by notice to the other parties may designate additional or different addresses for subsequent notices
or communications. 
 12. Remedies. Each Holder, in addition to being entitled to exercise all rights provided to it
herein, in the Indenture or in the Placement Agreement or granted by law, including recovery of liquidated or other damages, will be entitled to specific performance of its 

  
 20 

 
rights under this Agreement. The Company agrees that monetary damages would not be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Agreement and
hereby agrees to waive in any action for specific performance the defense that a remedy at law would be adequate. 
 13.
Successors. This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors and assigns, including, without the need for an express assignment or any consent by the Company thereto,
subsequent Holders of Securities and the New Securities. The Company hereby agrees to extend the benefits of this Agreement to any Holder of Securities and the New Securities, and any such Holder may specifically enforce the provisions of this
Agreement as if an original party hereto. 
 14. Jurisdiction. Each of the parties hereto agrees that any suit, action or
proceeding arising out of or based upon this Agreement or the transactions contemplated hereby may be instituted in any State or U.S. federal court in The City of New York and County of New York, and waives any objection which it may now or
hereafter have to the laying of venue of any such proceeding, and irrevocably submits to the jurisdiction of such courts in any suit, action or proceeding. The Company hereby appoints C T Corporation, 111 Eighth Avenue, New York, New York 10011, as
its authorized agent (the “Authorized Agent”) upon whom process may be served in any suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated herein which may be instituted in any State or
U.S. federal court in The City of New York and County of New York, by any Holder or the Placement Agents, the directors, officers, employees and agents of any Holder or the Placement Agents, or by any person who controls any Holder or the Placement
Agents, and expressly accepts the jurisdiction of any such court in respect of any such suit, action or proceeding. The Company hereby represents and warrants that the Authorized Agent has accepted such appointment and has agreed to act as said
agent for service of process, and the Company agrees to take any and all action, including the filing of any and all documents that may be necessary to continue such appointment in full force and effect as aforesaid. Service of process upon the
Authorized Agent shall be deemed, in every respect, effective service of process upon the Company. The Company further agrees to take any and all action, including the execution and filing of any and all such documents and instruments, as may be
necessary to continue such designation and appointment in full force and effect so long as any of the Securities shall be outstanding. To the extent that the Company may acquire any immunity from jurisdiction of any court or from any legal process
(whether through service of notice, attachment prior to judgment, attachment in aid of execution, execution or otherwise) with respect to itself or its property, it hereby irrevocably waives such immunity in respect of this Agreement, to the fullest
extent permitted by law. 
 15. Currency. Each reference in this Agreement to U.S. dollars (the “relevant
currency”) is of the essence. To the fullest extent permitted by law, the obligation of the Company in respect of any amount due under this Agreement will, notwithstanding any payment in any other currency (whether pursuant to a judgment or
otherwise), be discharged only to the extent of the amount in the relevant currency that the party entitled to receive such payment may, in accordance with its normal procedures, purchase with the sum paid in such other currency (after any premium
and costs of exchange) on the Business Day immediately following the day on which such party receives such payment. If the amount in the relevant currency that may be so purchased for any reason falls short of the amount originally due, the Company
will pay such 

  
 21 

 
additional amounts, in the relevant currency, as may be necessary to compensate for the shortfall. Any obligation of the Company not discharged by such payment will, to the fullest extent
permitted by applicable law, be due as a separate and independent obligation and, until discharged as provided herein, will continue in full force and effect. 
 16. Waiver of Immunity. To the extent that the Company has or hereafter may acquire any immunity (sovereign or otherwise) from any legal action, suit or proceeding, from jurisdiction of any court
or from set-off or any legal process (whether service or notice, attachment in aid or otherwise) with respect to itself or any of its property, the Company hereby irrevocably waives and agrees not to plead or claim such immunity in respect of its
obligations under this Agreement. 
 17. Third Party Beneficiary. The Holders shall be third party beneficiaries to the
agreements made hereunder between the Company, on the one hand, and the Placement Agents, on the other hand, and shall have the right to enforce such agreements directly to the extent it deems such enforcement necessary or advisable to protect its
rights or the rights of Holders hereunder. 
 18. Counterparts. This Agreement may be signed in one or more counterparts,
each of which shall constitute an original and all of which together shall constitute one and the same agreement. 
 19.
Headings. The section headings used herein are for convenience only and shall not affect the construction hereof. 
 20.
Applicable Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed in the State of New York. 

21. Severability. In the event that any one of more of the provisions contained herein, or the application thereof in any
circumstances, is held invalid, illegal or unenforceable in any respect for any reason, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions hereof shall not be in any way impaired or
affected thereby, it being intended that all of the rights and privileges of the parties shall be enforceable to the fullest extent permitted by law. 
 22. Securities Held by the Company, etc. Whenever the consent or approval of Holders of a specified percentage of principal amount of Securities or New Securities is required hereunder, Securities
or New Securities, as applicable, held by the Company or its Affiliates (other than subsequent Holders of Securities or New Securities if such subsequent Holders are deemed to be Affiliates solely by reason of their holdings of such Securities or
New Securities) shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage. 

  
 22 

 If the foregoing is in accordance with your understanding of our agreement, please sign and
return to us the enclosed duplicate hereof, whereupon this letter and your acceptance shall represent a binding agreement between the Company and the Placement Agents. 

 

			
	Very truly yours,
	
	 KANSAS CITY SOUTHERN de MÉXICO,
       S.A. de C.V.

		
	By:	 	 /s/ Michael W. Upchurch

		 	Name: Michael W. Upchurch
		 	Title: Chief Financial Officer

 The foregoing
Agreement is hereby 
 confirmed and accepted as of the 
 date first above written. 
 Merrill Lynch, Pierce, Fenner & Smith 

Incorporated 
 Acting severally
on behalf of themselves and the 
 several Placement Agents. 
  

			
	 By:
	 	 Merrill Lynch, Pierce, Fenner & Smith
                     Incorporated

 

			
	By:	 	 /s/ Stephan Jaeger

		 	Name: Stephan Jaeger
		 	Title: Managing Director

 Registration
Rights Agreement 

 ANNEX A 
 Each broker-dealer that receives new securities for its own account pursuant to the Exchange Offer must acknowledge that it will deliver a prospectus in connection with any resale of such new securities.
The Letter of Transmittal states that by so acknowledging and by delivering a prospectus, a broker-dealer will not be deemed to admit that it is an “underwriter” within the meaning of the Act. This prospectus, as it may be amended or
supplemented from time to time, may be used by a broker-dealer in connection with resales of new securities received in exchange for securities where such securities were acquired by such broker-dealer as a result of market-making activities or
other trading activities. The company has agreed that, starting on the expiration date and ending on the close of business one year after the expiration date, it will make this prospectus available to any broker-dealer for use in connection with any
such resale. See “Plan of Distribution”. 
 Registration Rights Agreement 

 ANNEX B 
 Each broker-dealer that receives new securities for its own account in exchange for securities, where such securities were acquired by such broker-dealer as a result of market-making activities or other
trading activities, must acknowledge that it will deliver a prospectus in connection with any resale of such new securities. See “Plan of Distribution”. 
 Registration Rights Agreement 

 ANNEX C 
 PLAN OF DISTRIBUTION 
 Each broker-dealer that receives new securities for
its own account pursuant to the Exchange Offer must acknowledge that it will deliver a prospectus in connection with any resale of such new securities. This prospectus, as it may be amended or supplemented from time to time, may be used by a
broker-dealer in connection with resales of new securities received in exchange for securities where such securities were acquired as a result of market-making activities or other trading activities. The company has agreed that, starting on the
expiration date and ending on the close of business one year after the expiration date, it will make this prospectus, as amended or supplemented, available to any broker-dealer for use in connection with any such resale. 

The company will not receive any proceeds from any sale of new securities by brokers-dealers. New securities received by broker-dealers
for their own account pursuant to the Exchange Offer may be sold from time to time in one or more transactions in the over-the-counter market, in negotiated transactions, through the writing of options on the new securities or a combination of such
methods of resale, at market prices prevailing at the time of resale, at prices related to such prevailing market prices or negotiated prices. Any such resale may be made directly to purchasers or to or through brokers or dealers who may receive
compensation in the form of commissions or concessions from any such broker-dealer and/or the purchasers of any such new securities. Any broker-dealer that resells new securities that were received by it for its own account pursuant to the Exchange
Offer and any broker or dealer that participates in a distribution of such new securities may be deemed to be an “underwriter” within the meaning of the Act and any profit of any such resale of new securities and any commissions or
concessions received by any such persons may be deemed to be underwriting compensation under the Act. The Letter of Transmittal states that by acknowledging that it will deliver and by delivering a prospectus, a broker-dealer will not be deemed to
admit that it is an “underwriter” within the meaning of the Act. 
 For a period of one year after the expiration
date, the company will promptly send additional copies of this prospectus and any amendment or supplement to this prospectus to any broker-dealer that requests such documents in the Letter of Transmittal. The company has agreed to pay all expenses
incident to the Exchange offer (including the expenses of one counsel for the holder of the securities) other than commissions or concessions of any brokers or dealers and will indemnify the holders of the securities (including any broker-dealers)
against certain liabilities, including liabilities under the Act. 
 [If applicable, add information required by Regulation S-K
Items 507 and/or 508.] 
 Registration Rights Agreement 

 ANNEX D 
 Rider A 
 PLEASE FILL IN YOUR NAME AND ADDRESS BELOW IF YOU ARE A BROKER-DEALER AND WISH TO
RECEIVE 10 ADDITIONAL COPIES OF THE PROSPECTUS AND 10 COPIES OF ANY AMENDMENTS OR SUPPLEMENTS THERETO. 
  

			
	Name:	 	  

	Address:	 	  

		 	  

 Rider B 
 If the undersigned is not a Broker-Dealer, the undersigned represents that it
acquired the New Securities in the ordinary course of its business, it is not engaged in, and does not intend to engage in, a distribution of New Securities and it has no arrangements or understandings with any person to participate in a
distribution of the New Securities nor will it have any such arrangements or understandings upon consummation of the Exchange Offer. If the undersigned is a Broker-Dealer that will receive New Securities for its own account in exchange for
Securities, it represents that the Securities to be exchanged for New Securities were acquired by it as a result of market-making activities or other trading activities and acknowledges that it will deliver a prospectus in connection with any resale
of such New Securities; however, by so acknowledging and by delivering a prospectus, the undersigned will not be deemed to admit that it is an “underwriter” within the meaning of the Act. 

Registration Rights AgreementPlacement Agreement

 Exhibit 10.1 
 EXECUTION COPY 
 KANSAS CITY SOUTHERN de MÉXICO, S.A. de C.V.

 $185,000,000 6.625% Senior Notes due 2020 
 PLACEMENT AGREEMENT 
 December 14, 2010 

 December 14, 2010 

Merrill Lynch, Pierce, Fenner & Smith 
 Incorporated 
 J.P. Morgan Securities LLC 
 Scotia Capital (USA) Inc. 
 BBVA Securities Inc. 

Citigroup Global Markets Inc. 
 UBS Securities
LLC 
 c/o Merrill Lynch, Pierce, Fenner & Smith 
 Incorporated 
 One Bryant Park 
 New York, New York 10036 
 Dear Sirs and Mesdames: 

Kansas City Southern de México, S.A. de C.V. (formerly known as TFM, S.A. de C.V.) (the “Company”), a sociedad
anónima de capital variable organized under the laws of the United Mexican States (“Mexico”), proposes to issue and sell to the several purchasers named in Schedule I hereto (the “Placement Agents”),
acting through Merrill Lynch, Pierce, Fenner & Smith Incorporated as representative (the “Representative”), $185,000,000 aggregate principal amount of its 6.625% Senior Notes due December 15, 2020 (the
“Securities”) to be issued pursuant to the provisions of an Indenture to be executed on or about December 20, 2010 (the “Indenture”) between the Company and U.S. Bank National Association, as Trustee (the
“Trustee”). 
 The Securities will be offered without being registered under the Securities Act of 1933, as
amended (the “Securities Act”), to people reasonably believed to be qualified institutional buyers in compliance with the exemption from registration provided by Rule 144A under the Securities Act and in offshore transactions in
reliance on Regulation S under the Securities Act (“Regulation S”). 
 The Placement Agents and their direct
and indirect transferees will be entitled to the benefits of a Registration Rights Agreement to be executed on or about December 20, 2010 between the Company and the Placement Agents (the “Registration Rights Agreement”).

 In connection with the sale of the Securities, the Company has prepared a preliminary offering memorandum (the
“Preliminary Memorandum”) and will prepare a final offering memorandum (the “Final Memorandum” and, with the Preliminary Memorandum, each a “Memorandum”) including or incorporating

  
 1 

 
by reference a description of the terms of the Securities, the terms of the offering and a description of the Company. “Time of Sale Memorandum” means the Preliminary Memorandum
together with the information set forth on Schedule II to this Agreement that has been prepared and delivered by the Company to the Placement Agents in connection with the offering of the Securities. The “Applicable Time” means 3:38
p.m. Eastern Standard Time on December 14, 2010. Reference to “this Agreement” shall mean this Placement Agreement. 
 1. Representations and Warranties. The Company represents and warrants to, and agrees with, you that: 
 (a) (i) The Time of Sale Memorandum, at the Applicable Time, did not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light
of the circumstances under which they were made, not misleading, and (ii) the Preliminary Memorandum does not contain and the Final Memorandum, as of its date and as of the Closing Date (as defined below), will not contain any untrue statement
of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and warranties set forth in this paragraph do
not apply to statements or omissions in the Time of Sale Memorandum or either Memorandum based upon information relating to any Placement Agent furnished to the Company in writing by such Placement Agent through you expressly for use therein, it
being understood and agreed that the only such information furnished by or on behalf of any Placement Agent consists of the information described as such in Section 8(b) hereof. 

(b) The Company (including its agents and representatives, other than the Placement Agents in their capacity as such) has
not prepared, made, used, authorized, approved or referred to and will not prepare, make, use, authorize, approve or refer to any written communication that constitutes an offer to sell or solicitation of an offer to buy the Securities (an
“Issuer Written Communication”) (other than the Final Memorandum, the Time of Sale Memorandum and any electronic roadshow). 
 (c) The Company has been duly incorporated, is validly existing as a sociedad anónima de capital variable under the laws of Mexico in good standing (to the extent applicable), has the
corporate power and authority to own, lease and operate its property and to conduct its business as described in the Time of Sale Memorandum and each Memorandum and is duly qualified to transact business and is in good standing (to the extent
applicable) in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires 

  
 2 

 
such qualification, except to the extent that the failure to be so qualified or be in good standing (to the extent applicable) would not reasonably be expected to have a material adverse effect
on the Company and its subsidiaries, taken as a whole. 
 (d) Each of the subsidiaries of the Company has been
duly organized, is validly existing and in good standing (to the extent applicable) under the laws of the jurisdiction of its incorporation, has the corporate power and authority to own, lease and operate its property and to conduct its business as
described in the Time of Sale Memorandum and each Memorandum and is duly qualified to transact business and is in good standing (to the extent applicable) in each jurisdiction in which the conduct of its business or its ownership or leasing of
property requires such qualification, except to the extent that the failure to be so qualified or be in good standing (to the extent applicable) would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries,
taken as a whole; all of the issued shares of capital stock of each of the subsidiaries held by the Company have been duly and validly authorized and issued, are fully paid and non-assessable and are owned directly or indirectly by the Company, free
and clear of all liens, encumbrances, equities or claims other than the shares (acciones) and/or equity quotas (partes sociales) representing 100% of the stated capital (capital social) of the Company’s subsidiaries,
Arrendadora KCSM, S. de R.L. de C.V., Highstar Harbor Holdings México, S. de R.L. de C.V., MTC Puerta México, S. de R.L. de C.V. and Vamos a México, S.A. de C.V., which have been pledged by the Company, its subsidiaries and
affiliates as collateral for the secured credit agreement, dated as of August 30, 2010, entered into by and between the Company, the lenders defined therein, The Bank of Nova Scotia, as administrative agent for the lenders, Scotiabank Inverlat,
S.A., Institución de Banca Múltiple, Grupo Financiero Scotiabank Inverlat, as collateral agent and Scotia Capital and Banc of America Securities LLC, as joint lead arrangers and joint bookrunners. 

(e) This Agreement has been duly authorized, executed and delivered by the Company. 

(f) The capitalization of the Company conforms as to legal matters to the description thereof contained in the Time of
Sale Memorandum and the Final Memorandum. 
 (g) The Securities have been duly authorized and, when executed and
authenticated in accordance with the provisions of the Indenture and delivered to and paid for by the Placement Agents in accordance with the terms of this Agreement, will be valid and binding

  
 3 

 
obligations of the Company, enforceable against the Company in accordance with their terms, subject to applicable concurso mercantil, bankruptcy, insolvency and similar laws affecting
creditors’ rights generally and equitable principles of general applicability, and will be entitled to the benefits of the Indenture pursuant to which such Securities are to be issued, and the Registration Rights Agreement. 

(h) The Registration Rights Agreement has been duly authorized and, on the Closing Date, will have been duly executed and
delivered by, and will constitute a valid and binding agreement of, the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by applicable concurso mercantil, bankruptcy,
insolvency and similar laws affecting creditors’ rights generally and equitable principles of general applicability and except as rights to indemnification under the Registration Rights Agreement may be limited by applicable law. 

(i) The Indenture has been duly authorized by the Company and, at the Closing Date, will have been duly executed and
delivered by the Company and will constitute a valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by applicable concurso mercantil,
bankruptcy, insolvency and similar laws affecting creditors’ rights generally and equitable principles of general applicability. On the Closing Date, the Indenture will conform in all material respects to the requirements of the Trust Indenture
Act of 1939, as amended (the “TIA”), applicable to an indenture qualified thereunder. 
 (j) The
execution and delivery by the Company of, and the performance by the Company of its obligations under this Agreement, the Indenture, the Registration Rights Agreement and the Securities (the “Transaction Documents”) and the
consummation of the transactions contemplated therein have been duly authorized by the Company, the Company has all power and authority to execute, deliver and perform its obligations under the Transaction Documents and the execution, delivery and
performance by the Company of its obligations under the Transaction Documents and the consummation of the transactions contemplated therein, including, without limitation, the application of the proceeds from the sale of the Securities as described
in the Memorandum and the Time of Sale Memorandum, will not (i) contravene, conflict with or constitute a breach of, or default under any provision of (x) the estatutos sociales or any other organizational document of the Company or
any of its subsidiaries, (y) the Concession (as defined below) or any law applicable to the Company and its operations (including, without limitation, its subsidiaries) or (z) any agreement or other instrument binding upon the

  
 4 

 
Company, any of its subsidiaries or Kansas City Southern (“KCS”) that is included in or incorporated by reference into the Annual Report on Form 10-K for the year ended
December 31, 2009, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, the Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 and the Quarterly Report on Form 10-Q for the quarter ended
September 30, 2010 of the Company or KCS, (ii) result in an event or condition which gives the holder of any note, debenture, or other evidence of indebtedness that is included in or incorporated by reference into the Annual Report on Form
10-K for the year ended December 31, 2009, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, the Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 and the Quarterly Report on Form 10-Q for the
quarter ended September 30, 2010 of the Company or KCS (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its
subsidiaries, or (iii) contravene, conflict with or constitute a breach of, or default under any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any of its subsidiaries and their
respective operations, except to the extent that such violation, breach or default described in item (iii) of this Section 1(g) would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken
as a whole. 
 (k) No consent, approval, authorization or order of, or qualification with, any governmental body
or agency is required for the performance by the Company of its obligations under the Transaction Documents, except (i) such as may be required (x) by the securities or Blue Sky laws of the various states in connection with the offer and
sale of the Securities, (y) by U.S. Federal and state securities laws with respect to the Company’s obligations under the Registration Rights Agreement, and (z) the filing of a notice with the Comisión Nacional Bancaria y de
Valores of Mexico (the “CNBV”) regarding the issuance of the Securities and the terms thereof, such filing to be delivered by the Company to the CNBV prior to the Closing Date, and (ii) such consents, approvals,
authorizations, filings or orders as have been obtained. 
 (l) The Company holds a valid concession title
granted in 1997 for a period of 50 years, which may be renewed under certain conditions for an additional period of up to 50 years, to provide freight transportation services over its rail lines as described in the Time of Sale Memorandum and the
Final Memorandum (the “Concession”). The Concession is currently, and has at all times since its granting been, in full force and effect and no proceeding to revoke, suspend or lapse the effectiveness of the Concession is pending
before or, to the Company’s knowledge, threatened by any Mexican federal governmental authority. 

  
 5 

 
Except for the rights held by the government of Mexico as described in the Time of Sale Memorandum and the Final Memorandum, the Concession and the Company’s rights deriving therefrom are
free and clear of any liens and encumbrances. 
 (m) The Company and each of its subsidiaries own, possess or has
obtained all licenses, permits, certificates, consents, orders, approvals and other authorizations from, including, without limitation, the Concession, and has made all declarations and filings with, all federal, state, local and other governmental
authorities (including foreign regulatory agencies), all self-regulatory organizations and all courts and other tribunals, domestic or foreign, necessary to own or lease, as the case may be, and to operate its properties and to carry on its business
as conducted as of the date hereof and as described in the Time of Sale Memorandum and the Final Memorandum, except to the extent that the failure to own, possess or obtain such licenses, permits, certificates, consents, orders, approvals and other
authorizations would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole; and neither the Company nor any of its subsidiaries has received any notice of any proceeding relating to
revocation or modification of any such license, permit, certificate, consent, order, approval or other authorization which, individually or in the aggregate, if subject to an unfavorable or adverse decision or ruling, would reasonably be expected to
result in a material adverse effect on the Company and its subsidiaries, taken as a whole. 
 (n) The historical
audited consolidated financial statements and notes thereto of the Company included, or incorporated by reference, in the Time of Sale Memorandum and the Final Memorandum (i) have been prepared in accordance with U.S. generally accepted
accounting principles (“U.S. GAAP”) (prior historical audited consolidated financial statements and notes of the Company prepared in accordance with International Financial Reporting Standards (“IFRS”) have been
re-stated in accordance with U.S. GAAP), (ii) present fairly in all material respects the financial condition, results of operations and cash flows of the Company and each of its subsidiaries taken as a whole, and (iii) comply as to form
in all material respects with the applicable accounting requirements of the Securities Act which would be applicable if the offer of the Securities were required to be registered under the Securities Act; the summary financial data in the Time of
Sale Memorandum and the Final Memorandum, including all items reconciled to U.S. GAAP, fairly present, on the basis stated in the Time of Sale Memorandum and the Final Memorandum, the information included therein. No other financial statements are
required to be included in the Time of Sale Memorandum or the Final Memorandum. 

  
 6 

 (o) The Company and each of its subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations; (ii) all transactions are recorded as necessary to permit
preparation of financial statements in accordance with U.S. GAAP and to maintain asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. 
 (p) The Company maintains an effective system of “disclosure controls and procedures” (as defined in Rule 13a-15(e) of the Exchange Act) that is designed to ensure that information required to
be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms, including controls and procedures
designed to ensure that such information is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure. The Company has carried out evaluations of the effectiveness of its
disclosure controls and procedures as required by Rule 13a-15 of the Exchange Act. 
 (q) KPMG LLP
(“KPMG”), who has audited the consolidated financial statements of the Company and its subsidiaries and delivered its report with respect to the consolidated financial statements of the Company and its subsidiaries as of
December 31, 2007, December 31, 2008 and December 31, 2009 included, or incorporated by reference, in the Time of Sale Memorandum and the Final Memorandum, are independent public accountants with respect to the Company within the
meaning and as required by the Securities Act and all the applicable rules and regulations published thereunder and the rules and regulations of the Public Company Accounting Oversight Board. 

(r) The Company and each of its subsidiaries has filed all tax returns (foreign, national, local or other) required to be
filed and has paid all taxes required to be paid by it and any other assessment, fine or penalty levied against it, to the extent that any of the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being
contested in good faith and except where the failure to file or pay would not, individually or in the aggregate, result in a material adverse effect on the Company and its subsidiaries, taken as a whole. 

(s) Except as described in the Time of Sale Memorandum and Final Memorandum, payments in respect of the Transaction
Documents 

  
 7 

 
(including the transfer, sale and delivery of the Securities), are not subject under the current laws of any applicable jurisdiction or any political subdivision thereof or therein to any
withholdings or similar charges for or on account of taxation or otherwise other than taxes imposed on the income or gain of the Placement Agents whose net income or gains are otherwise subject to any tax by Mexico or any political subdivision
thereof or therein. 
 (t) Except as described in the Time of Sale Memorandum and Final Memorandum, payments made
to a foreign holder (as defined in the Time of Sale Memorandum and each Memorandum) by the Company under the Securities will not be subject under the current laws of Mexico or any political subdivision thereof to any withholdings or similar charges
for or on account of taxation. 
 (u) Except as described in the Time of Sale Memorandum and Final Memorandum,
non-Mexican holders of the Securities will not be deemed resident, domiciled, carrying on business or subject to taxation in Mexico solely by reason of the execution, delivery, performance or enforcement of each of the Transaction Documents.

 (v) There are no stamp or other issuance or transfer taxes or duties or other similar fees or charges required
to be paid in connection with the execution and delivery of this Agreement or the issuance or sale by the Company of the Securities. 
 (w) Since the respective dates as of which information is given in the Time of Sale Memorandum and each Memorandum, there has not occurred any material adverse change, or any development involving a
prospective material adverse change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Preliminary Memorandum. 

(x) Neither the Company nor any of its subsidiaries is (i) in violation, breach of, or default under any provision of
(x) the estatutos sociales or any other organizational document of the Company or any of its subsidiaries, (y) the Concession or any law applicable to the Company and its operations (including, without limitation, its subsidiaries)
or (z) any agreement or other instrument binding upon the Company, any of its subsidiaries or KCS that is included in or incorporated by reference into the Annual Report on Form 10-K for the year ended December 31, 2009, the Quarterly
Report on Form 10-Q for the quarter ended March 31, 2010, the Quarterly Report on Form 10-Q for the quarter ended June 30, 2010 and the Quarterly Report on Form 10-Q for the quarter ended September 30,

  
 8 

 
2010 of the Company or KCS, (ii) currently subject to an event or condition which gives the holder of any note, debenture, or other evidence of indebtedness that is included in or
incorporated by reference into the Annual Report on Form 10-K for the year ended December 31, 2009, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2010, the Quarterly Report on Form 10-Q for the quarter ended
June 30, 2010 and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2010 of the Company or KCS (or any person acting on such holder’s behalf) the right to require the repurchase, redemption or repayment of all or a
portion of such indebtedness by the Company or its subsidiaries, or (iii) in violation, breach of, or default under any judgment, order or decree of any governmental body, agency or court having jurisdiction over the Company or any of its
subsidiaries, except to the extent that any such violation, breach or default described in items (i)(z) or (iii) of this Section 1(t) would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries,
taken as a whole. 
 (y) There are no legal or governmental proceedings pending or, to the Company’s
knowledge, threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject other than proceedings that are accurately described in all material respects in
the Time of Sale Memorandum and each Memorandum and proceedings that would not reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole, or on the power or ability of the Company to perform its
obligations under the Transaction Documents or to consummate the transactions contemplated by the Time of Sale Memorandum and the Final Memorandum. 
 (z) The Company and each of its subsidiaries (i) are in compliance with any and all applicable foreign, federal, state and municipal laws and regulations relating to the protection of human health
and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants, including, without limitation, the environmental obligations under the Concession (“Environmental Laws”), (ii) have received
all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance with all terms and conditions of any such permit, license or approval, except where
such noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, singly or in the aggregate, have a
material adverse effect on the Company and its subsidiaries, taken as a whole. 

  
 9 

 (aa) There are no costs or liabilities associated with Environmental Laws
(including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any
potential liabilities to third parties) which would, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole. 

(bb) No labor dispute with the employees of the Company or any of its subsidiaries exists or, to the knowledge of the
Company or any of its subsidiaries, is threatened or, to the Company’s knowledge, is imminent, and to the knowledge of the Company and any of its subsidiaries there is no existing or imminent labor disturbance by the employees of any of their
respective principal suppliers, contractors or customers that would be reasonably likely to have a material adverse effect on the Company and its subsidiaries, taken as a whole. 

(cc) The Company and each of its subsidiaries have not, nor to the knowledge of the Company, has any director, officer,
agent, employee or other person associated with or acting on behalf of the Company or any of its subsidiaries, used any of the funds of the Company or any of its subsidiaries for any contribution, gift, entertainment or other expense relating to
political activity in contravention of any applicable law, made any direct or indirect payment to any foreign or domestic government official or employee in contravention of any applicable law from any of the funds of the Company or any of its
subsidiaries, or made any bribe, rebate, payoff influence payment, kickback or other unlawful payment in contravention of any applicable law, including the U.S. Foreign Corrupt Practices Act. 

(dd) The Company and each of its subsidiaries is insured by insurers of recognized financial responsibility against such
losses and risks and in such amounts as are prudent and customary for companies engaged in the same or similar businesses; all such policies covering any of their business, assets, employees, officers and directors are in full force and effect; the
Company and each of its subsidiaries is in compliance with the terms of such policies and instruments in all material respects; and there are no claims by the Company or any of its subsidiaries under any such policy or instrument as to which any
insurance company is denying liability or defending under a reservation of rights clause; and neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when
such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue their businesses. 

  
 10 

 (ee) The Company and each of its subsidiaries have no immunity from
jurisdiction of any court of (i) any jurisdiction in which they own or lease property or assets, (ii) the United States or the State of New York or (iii) Mexico or any political subdivision thereof or from any legal process (whether
through service of notice, attachment prior to judgment, attachment in aid of execution, execution or otherwise) with respect to themselves or their property and assets or this Agreement, the Indenture or the Registration Rights Agreement or actions
to enforce judgments in respect thereof. 
 (ff) No relationship, direct or indirect, exists between the Company
or any of its subsidiaries on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company or any of its subsidiaries on the other hand, which would be required by the Securities Act, if the offer of the Securities
were required to be registered under the Securities Act, to be described in the Time of Sale Memorandum and the Final Memorandum which is not so described. 
 (gg) The Company is not and does not expect to become a passive foreign investment company as defined in Section 1297 of the U.S. Internal Revenue Code of 1986, as amended, and the regulations
promulgated thereunder. 
 (hh) Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department. 

(ii) The Company and each of its subsidiaries are in material compliance with applicable Mexican and U.S. anti-terrorism
and anti-money laundering rules and regulations, including Title III of the USA Patriot Act, the regulations administered by the U.S. Department of the Treasury, including its Office of Foreign Assets Control, and other applicable Mexican and U.S.
federal, state or non-U.S. anti-money laundering laws and regulations (collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator
involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending, to the knowledge of the Company, or threatened. 
 (jj) The Company is subject to and is reporting in accordance with the requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) and all documents incorporated by reference in the Time of Sale Memorandum and the Final Memorandum comply as to form in all material respects with the applicable requirements of the Exchange Act. 

  
 11 

 (kk) The Company has not paid or agreed to pay to any person any
compensation for soliciting another to purchase any securities of the Company, except as contemplated in this Agreement. 
 (ll) The statements in, or incorporated by reference in, the Time of Sale Memorandum and the Final Memorandum under the headings “Capitalization”, “Business”, “Description of the
Notes”, and “Taxation” fairly summarize the matters therein described. 
 (mm) There is and has
been no failure on the part of the Company and to the Company’s knowledge, after reasonable inquiry, any of the Company’s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act of 2002
and the rules and regulations promulgated in connection therewith (the “Sarbanes-Oxley Act”) applicable to the Company as of the date hereof. 
 (nn) Until March 31, 2005 the Company was a “foreign issuer” (as defined in Regulation S). Since April 1, 2005, the Company has been a “domestic issuer” (as defined in
Regulation S) and has adopted all the necessary measures consistent with its status as such, and the Company reasonably believes that there is no substantial U.S. market interest (as defined in Regulation S) in its debt securities. 

(oo) The Company is not, and after giving effect to the offering and sale of the Securities and the application of the
proceeds thereof as described in the Time of Sale Memorandum and the Final Memorandum will not be, required to register as an “investment company” as such term is defined in the Investment Company Act of 1940, as amended. 

(pp) Neither the Company nor any affiliate (as defined in Rule 501(b) of Regulation D under the Securities Act, and, for
avoidance of doubt, including KCS, an “Affiliate”)) of the Company has directly, or through any agent, (i) sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any security (as defined in the
Securities Act) which is or will be integrated with the sale of the Securities in a manner that would require the registration under the Securities Act of the Securities or (ii) offered, solicited offers to buy or sold the Securities by any
form of general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Securities Act. 

  
 12 

 (qq) None of the Company, its Affiliates or any person acting on its or
their behalf has engaged or will engage in any directed selling efforts (within the meaning of Regulation S) with respect to the Securities and the Company and its Affiliates and any person acting on its or their behalf have complied and will comply
with the offering restrictions requirement of Regulation S. 
 (rr) It is not necessary in connection with the
offer, sale and delivery of the Securities to the Placement Agents or the resale to subsequent purchasers in the manner contemplated by this Agreement to register the Securities under the Securities Act or to qualify the Indenture under the TIA.

 (ss) The Securities satisfy the requirements set forth in Rule 144A(d)(3) under the Securities Act.

 (tt) The Company has validly, legally, effectively and irrevocably submitted to the personal jurisdiction of
any state or Federal court in the Borough of Manhattan, The City of New York, New York, has validly, legally, effectively and irrevocably waived any objection to the venue of a proceeding in any such court, and has validly, legally, effectively and
irrevocably appointed C T Corporation as its authorized agent for service of process. 
 2. Agreements to Sell and
Purchase. The Company hereby agrees to sell to the several Placement Agents, and each Placement Agent, upon the basis of the representations and warranties herein contained, but subject to the conditions hereinafter stated, agrees, severally and
not jointly, to purchase from the Company the aggregate principal amount of the Securities set forth in Schedule I hereto opposite its name at a purchase price of 98.00% of the aggregate principal amount thereof (the “Purchase
Price”). 
 The Company hereby agrees that, without the prior written consent of the Representative, it will not,
during the period beginning on the date hereof and continuing to and including the Closing Date, offer, sell, contract to sell or otherwise dispose of any debt of the Company or warrants to purchase debt of the Company substantially similar to the
Securities (other than the sale of the Securities under this Agreement). 
 3. Terms of Offering. You have advised the
Company that the Placement Agents will make an offering of the Securities purchased by the Placement Agents hereunder on the terms to be set forth in the Time of Sale Memorandum, as soon as practicable after this Agreement is entered into as in your
judgment is advisable. 

  
 13 

 4. Payment and Delivery. Payment for the Securities shall be made to the Company in
Federal or other funds immediately available in New York City against delivery of such Securities for the respective accounts of the several Placement Agents at 10:00 a.m., New York City time, on December 20, 2010, or at such other time on the
same or such other date, not later than December 20, 2010, as shall be designated in writing by you. The time and date of such payment are hereinafter referred to as the “Closing Date.” 

The Securities shall be in definitive form or global form, as specified by you, and registered in such names and in such denominations as
you shall request in writing not later than one full business day prior to the Closing Date. The Securities shall be delivered to you on the Closing Date for the respective accounts of the several Placement Agents, with any transfer taxes payable in
connection with the transfer of the Securities to the Placement Agents duly paid, against payment of the Purchase Price therefor. 
 5. Conditions to the Placement Agents’ Obligations. The several obligations of the Placement Agents to purchase and pay for the Securities on the Closing Date are subject to the following
conditions: 
 (a) Subsequent to the execution and delivery of this Agreement and on or prior to the Closing
Date: 
 (i) there shall not have occurred any downgrading, nor shall any notice have been given of any intended
or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded the Company or any of the securities of the Company, KCS or any of their subsidiaries or in the
rating outlook for the Company by any “nationally recognized statistical rating organization,” as such term is defined for purposes of Rule 436(g)(2) under the Securities Act; 

(ii) the Company shall have obtained all consents, approvals, authorizations and orders of, and shall have duly made all
registrations, qualifications and filings with, any court or regulatory authority or other governmental agency or instrumentality, including without limitation the CNBV, required in connection with the issuance and sale of the Securities and the
execution, delivery and performance of this Agreement; and 
 (iii) there shall not have occurred any change, or
any development involving a prospective change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set

  
 14 

 
forth in the Time of Sale Memorandum provided to prospective purchasers of the Securities that, in your reasonable judgment, is material and adverse and that makes it, in your reasonable
judgment, impracticable or inadvisable to proceed with the offer, sale or delivery of the Securities on the terms and in the manner contemplated in the Time of Sale Memorandum. 

(b) The Placement Agents shall have received on the Closing Date a certificate, dated the Closing Date and signed by an
executive officer of the Company, to the effect set forth in Section 5(a)(i) and to the effect that the representations and warranties of the Company contained in this Agreement are true and correct as of the Closing Date and that the Company
has complied with all of the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date. The officer signing and delivering such certificate may rely upon his or her knowledge as
to proceedings threatened. 
 (c) The Placement Agents shall have received on the Closing Date an opinion of
White & Case LLP, outside U.S. counsel for the Company, dated the Closing Date, in form and substance satisfactory to the Representative. Such opinion shall be rendered to the Placement Agents at the request of the Company and shall so
state therein. 
 (d) The Placement Agents shall have received on the Closing Date an opinion of White &
Case, S.C., outside Mexican counsel for the Company, dated the Closing Date, in form and substance reasonably satisfactory to the Representative. Such opinion shall be rendered to the Placement Agents at the request of the Company and shall so state
therein. 
 (e) The Placement Agents shall have received on the Closing Date an in-house legal opinion from Edgar
Aguileta Gutiérrez, Associate General Counsel and Alternate Corporate Secretary of the Company, dated the Closing Date, in form and substance reasonably satisfactory to the Representative. Such opinion shall be rendered to the Placement
Agents at the request of the Company and shall so state therein. 
 (f) The Placement Agents shall have received
on the Closing Date an opinion of Shearman & Sterling LLP, U.S. counsel for the Placement Agents, dated the Closing Date, in form and substance reasonably satisfactory to the Representative. 

(g) The Placement Agents shall have received on the Closing Date an opinion of Mijares, Angoitia, Cortés y Fuentes,
S.C., Mexican counsel for the Placement Agents, dated the Closing Date, in form and substance reasonably satisfactory to the Representative. 

  
 15 

 (h) The Placement Agents shall have received on each of the date hereof and
the Closing Date a letter, dated the date hereof or the Closing Date, as the case may be, in form and substance satisfactory to the Representative, from KPMG, independent public accountants, containing statements and information of the type
ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial information contained in the Time of Sale Memorandum and the Final Memorandum; provided, however,
that the letter delivered on the Closing Date shall use a “cut-off date” not earlier than the date hereof. 
 (i) As of the Closing Date, the Company shall have entered into the Registration Rights Agreement and the Placement Agents shall have received executed counterparts thereof. 

(j) As of the Closing Date, the Company and the Trustee shall have entered into the Indenture and the Placement Agents
shall have received executed counterparts thereof. 
 6. Covenants of the Company. In further consideration of the
agreements of the Placement Agents contained in this Agreement, the Company covenants with each Placement Agent as follows: 
 (a) To furnish to you in New York City, without charge, prior to 10:00 a.m., New York City time on the business day next succeeding the date of this Agreement and during the period mentioned in
Section 6(b), as many electronic copies of the Time of Sale Memorandum, either Memorandum and any supplements and amendments thereto as you may reasonably request. 

(b) Before amending or supplementing the Time of Sale Memorandum or either Memorandum, to furnish to you a copy of each
such proposed amendment or supplement and not to use any such proposed amendment or supplement to which you reasonably object, provided that if, in the opinion of counsel to the Company, any such amendment or supplement shall be required by law or
regulation to be used, that the Company be permitted to use such amendment or supplement after taking into account such comments as you may reasonably make on the content, form or other aspects of such amendment or supplement. In addition, before
making, preparing, using, authorizing, approving or distributing any Issuer Written Communication, the Company will furnish to the Representative a copy of such Issuer Written Communication for review and will not make, prepare, use, authorize,
approve or distribute any such Issuer Written Communication to which the Representative reasonably objects. 

  
 16 

 (c) If the Time of Sale Memorandum is being used to solicit offers to buy
the Securities at a time when the Final Memorandum is not yet available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Memorandum in order to make
the statements therein, in the light of the circumstances, not misleading, or if, in the opinion of counsel for the Placement Agents, it is necessary to amend or supplement the Time of Sale Memorandum to comply with applicable law, forthwith to
prepare and furnish, at the Company’s own expense, to the Placement Agents upon request, either amendments or supplements to the Time of Sale Memorandum so that the statements in the Time of Sale Memorandum as so amended or supplemented will
not, in the light of the circumstances when delivered to a prospective purchaser, be misleading or so that the Time of Sale Memorandum, as amended or supplemented, will comply with law. 

(d) If, during such period after the date hereof and prior to the date on which all of the Securities shall have been sold
by the Placement Agents, any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Final Memorandum in order to make the statements therein, in the light of the circumstances when the Final Memorandum
is delivered to a purchaser, not misleading, or if, in the opinion of counsel for the Placement Agents, it is necessary to amend or supplement the Final Memorandum to comply with applicable law, forthwith to prepare and furnish, at its own expense,
to the Placement Agents, either amendments or supplements to the Final Memorandum so that the statements in the Final Memorandum as so amended or supplemented will not, in the light of the circumstances when the Final Memorandum is delivered to a
purchaser, be misleading or so that the Final Memorandum, as amended or supplemented, will comply with applicable law. 
 (e) To endeavor to qualify the Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions as you shall reasonably request. 

(f) Whether or not the transactions contemplated in this Agreement are consummated or this Agreement is terminated, to pay
or cause to be paid all expenses incident to the performance of its obligations under this Agreement. It is understood, however, that except as provided in this Section, Section 8, and the last paragraph of Section 10, or as otherwise
agreed by the parties hereto in writing, the Placement Agents will pay all of their costs and expenses, including fees and disbursements of their counsel, transfer taxes payable on resale of any of the Securities by them and any advertising expenses
connected with any offers they may make. 

  
 17 

 (g) Neither the Company nor any Affiliate will sell, offer for sale or
solicit offers to buy or otherwise negotiate in respect of any security (as defined in the Securities Act) which could be integrated with the sale of the Securities in a manner which would require the registration under the Securities Act of the
Securities. 
 (h) Not to solicit any offer to buy or offer or sell the Securities by means of any form of
general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) or in any manner involving a public offering within the meaning of Section 4(2) of the Securities Act. 

(i) While any of the Securities remain “restricted securities” within the meaning of the Securities Act, to make
available, upon request, to any seller of such Securities the information specified in Rule 144A(d)(4) under the Securities Act, unless the Company is then subject to Section 13 or 15(d) of the Exchange Act. 

(j) None of the Company, its Affiliates or any person acting on its or their behalf (other than the Placement Agents) will
engage in any directed selling efforts (as that term is defined in Regulation S) with respect to the Securities, and the Company and its Affiliates and each person acting on its or their behalf (other than the Placement Agents) will comply with the
offering restrictions requirement of Regulation S. 
 (k) During the period of one year after the Closing Date,
the Company will not, and will not permit any of its affiliates (as defined in Rule 144 under the Securities Act) to resell any of the Securities which constitute “restricted securities” under Rule 144 that have been reacquired by any of
them. 
 (l) Not to take any action prohibited by Regulation M under the Exchange Act in connection with the
distribution of the Securities contemplated hereby. 
 (m) To comply in all material respects with all applicable
securities and other laws, rules and regulations, including without limitation, the Sarbanes-Oxley Act, and to cause the officers and directors of the Company, in their capacities as such, to comply with such laws, rules and regulations, including
without limitation, the provisions of the Sarbanes-Oxley Act. 

  
 18 

 (n) To comply in all material respects with all matters imposed under the
U.S. securities laws applicable, from and after April 1, 2005, to entities that are not foreign private issuers under such laws, including, to the extent applicable, the preparation of the Company’s consolidated financial statements from
and after January 1, 2005 under U.S. GAAP. 
 7. Offering of Securities; Restrictions on Transfer. (a) Each
Placement Agent, severally and not jointly, represents and warrants that such Placement Agent is a qualified institutional buyer as defined in Rule 144A under the Securities Act (a “QIB”). Each Placement Agent, severally and not
jointly, agrees with the Company that (i) it will not solicit offers for, or offer or sell, such Securities by any form of general solicitation or general advertising (as those terms are used in Regulation D under the Securities Act) or in any
manner involving a public offering within the meaning of Section 4(2) of the Securities Act and (ii) it will solicit offers for such Securities only from, and will offer such Securities only to, persons that it reasonably believes to be
(A) in the case of offers inside the United States, QIBs and (B) in the case of offers outside the United States, to persons other than U.S. persons (“foreign purchasers,” which term shall include dealers or other
professional fiduciaries in the United States acting on a discretionary basis for foreign beneficial owners (other than an estate or trust)) in reliance upon Regulation S under the Securities Act that, in each case, in purchasing such Securities are
deemed to have represented and agreed as provided in the Time of Sale Memorandum under the caption “Transfer Restrictions”. 
 (b) Each Placement Agent, severally and not jointly, represents, warrants, and agrees with respect to offers and sales outside the United States that: 

(i) such Placement Agent understands that no action has been or will be taken in any jurisdiction by the Company that
would permit a public offering of the Securities, or possession or distribution of the Time of Sale Memorandum or either Memorandum or any other offering or publicity material relating to the Securities, in any country or jurisdiction where action
for that purpose is required; 
 (ii) such Placement Agent will comply with all applicable laws and regulations
in each jurisdiction in which it acquires, offers, sells or delivers Securities or has in its possession or distributes the Time of Sale memorandum or either Memorandum or any such other material, in all cases at its own expense; 

(iii) the Securities have not been registered under the Securities Act and may not be offered or sold within the United
States or to, or for the account or benefit of, U.S. persons except in accordance 

  
 19 

 
with Rule 144A or Regulation S under the Securities Act or pursuant to another exemption from the registration requirements of the Securities Act; 

(iv) such Placement Agent has offered the Securities and will offer and sell the Securities (A) as part of their
distribution at any time and (B) otherwise until 40 days after the later of the commencement of the offering and the Closing Date, only in accordance with Rule 903 of Regulation S or as otherwise permitted in Section 7(a);
accordingly, neither such Placement Agent, its Affiliates nor any persons acting on its or their behalf have engaged or will engage in any directed selling efforts (within the meaning of Regulation S) with respect to the Securities, and any such
Placement Agent, its Affiliates and any such persons have complied and will comply with the offering restrictions requirement of Regulation S; 
 (v) such Placement Agent (A) has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity
(within the meaning of Section 21 of the Financial Services and Markets Act 2000 (the “FSMA”)) received by it in connection with the offer of the Securities in circumstances in which Section 21(1) of the FSMA does not apply to
the Company; and (B) it has complied and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the Securities in, from or otherwise involving the United Kingdom; 

(vi) such Placement Agent understands that the Securities have not been and will not be registered with the Registro
Nacional de Valores (National Registry of Securities) maintained by the CNBV under the Securities and Exchange Law of Mexico (Ley del Mercado de Valores), and represents that it has not offered or sold, and agrees not to offer or sell,
directly or indirectly, any Securities in Mexico or for the account of any resident thereof, except pursuant to a private placement exemption set forth under Article 8 of the Securities and Exchange Law of Mexico and in compliance with applicable
provisions of Mexican Law or in accordance with an authorization to that effect; and 
 (vii) such Placement
Agent agrees that, at or prior to confirmation of sales of the Securities, it will have sent to each distributor, dealer or person receiving a selling concession, fee or other remuneration that purchases Securities from it during the restricted
period a confirmation or notice to substantially the following effect: 
 “The Securities covered hereby
have not been registered under the U.S. Securities Act of 1933 (the “Securities Act”) and may not be offered and sold within the United States or to, or for the account or benefit of, U.S. persons (i) as part of their distribution at
any time or (ii) otherwise until 40 days after the later of the commencement of the offering and the closing date, except in either case in accordance with Regulation S (or Rule 144A if available) under the Securities Act. Terms used above
have the meaning given to them by Regulation S.” 

  
 20 

 Terms used in this Section 7(b) have the meanings given to them by Regulation S. 

8. Indemnity and Contribution. (a) The Company agrees to indemnify and hold harmless each Placement Agent, each person, if
any, who controls any Placement Agent within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act, and each affiliate of any Placement Agent within the meaning of Rule 405 under the Securities Act from
and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) caused by any untrue statement or
alleged untrue statement of a material fact contained in the Time of Sale Memorandum or either Memorandum or any amendments or supplements thereto, or any of the supplemental marketing materials listed on Schedule III hereto, if any, or caused by
any omission or alleged omission to state therein a material fact necessary to make the statements therein in the light of the circumstances under which they were made not misleading, except insofar as such losses, claims, damages or liabilities are
caused by any such untrue statement or omission or alleged untrue statement or omission based upon information relating to any Placement Agent furnished to the Company in writing by such Placement Agent through you expressly for use therein, it
being understood and agreed that the only such information furnished by or on behalf of any Placement Agent consists of the information described as such in Section 8(b) hereof. 

(b) Each Placement Agent agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors, its officers and
each person, if any, who controls the Company within the meaning of either Section 15 of the Securities Act or Section 20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such Placement Agent, but only
with reference to information relating to such Placement Agent furnished to the Company in writing by such Placement Agent through you expressly for use in the Time of Sale Memorandum or either Memorandum or any amendments or supplements thereto.
The Company acknowledges that (i) the last full paragraph of the cover page of each Memorandum, (ii) the second sentence of the second full paragraph under the caption “Private Placement” in each Memorandum, (iii) the first
sentence of the eighth full paragraph under the caption “Private 

  
 21 

 
Placement” in each Memorandum and (iv) the ninth full paragraph under the caption “Private Placement” in each Memorandum constitute the only information furnished in writing
by or on behalf of the Placement Agents for inclusion in the documents referred to in the foregoing indemnity. 
 (c) In case
any proceeding (including any governmental investigation) shall be instituted involving any person in respect of which indemnity may be sought pursuant to Section 8(a) or 8(b), such person (the “indemnified party”) shall
promptly notify the person against whom such indemnity may be sought (the “indemnifying party”) in writing and the indemnifying party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the
indemnified party to represent the indemnified party and any others the indemnifying party may designate in such proceeding and shall pay the fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified
party shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i) the indemnifying party and the indemnified party shall have mutually agreed to the
retention of such counsel, (ii) the named parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would be
inappropriate due to actual or potential differing interests between them, (iii) the indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory to the indemnified party or (iv) the indemnified party
has reasonably concluded that there may be legal defenses available to it which are different from or in addition to those available to the indemnifying party. It is understood that the indemnifying party shall not, in respect of the legal expenses
of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all such indemnified parties and
that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall be designated in writing by the Representative, in the case of parties indemnified pursuant to Section 8(a), and by the Company, in the case of parties
indemnified pursuant to Section 8(b). The indemnifying party shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the
indemnifying party agrees to indemnify the indemnified party from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second and third sentences of this paragraph, the indemnifying party agrees that it shall be liable for any settlement of any proceeding
effected without its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii) such indemnifying party shall not have reimbursed the indemnified
party in accordance with such request prior to the date of such 

  
 22 

 
settlement. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any
indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless (i) such settlement includes an unconditional release of such indemnified party from all liability on claims that
are the subject matter of such proceeding and (ii) does not include any statements as to or any findings of fault, culpability or failure to act by or on behalf of any indemnified party. 

(d) To the extent the indemnification provided for in Section 8(a) or 8(b) is unavailable to an indemnified party or insufficient in
respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such losses, claims, damages or liabilities (i) in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Placement Agents on the other hand from the
offering of the Securities or (ii) if the allocation provided by clause 8(d)(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause 8(d)(i) above but
also the relative fault of the Company on the one hand and of the Placement Agents on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable
considerations. The relative benefits received by the Company on the one hand and the Placement Agents on the other hand in connection with the offering of the Securities shall be deemed to be in the same respective proportions as the net proceeds
from the offering of the Securities (before deducting expenses) received by the Company and the total discounts and commissions (after deducting reimbursements for expenses incurred by the Company) received by the Placement Agents, in each case as
set forth in the Time of Sale Memorandum and the Final Memorandum, bear to the aggregate offering price of the Securities. The relative fault of the Company on the one hand and of the Placement Agents on the other hand shall be determined by
reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Placement Agents and the
parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. The Placement Agents’ respective obligations to contribute pursuant to this Section 8 are several in
proportions to the respective principal amount of Securities they have purchased hereunder, and not joint. 
 (e) The Company
and the Placement Agents agree that it would not be just or equitable if contribution pursuant to Section 8(d) were determined by pro rata allocation (even if the Placement Agents were treated as one entity for such purpose) or by any
other method of allocation that does not take account of the 

  
 23 

 
equitable considerations referred to in Section 8(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in
Section 8(d) shall be deemed to include, subject to the limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim.
Notwithstanding the provisions of this Section 8, no Placement Agent shall be required to contribute any amount in excess of the discount and commissions received by it in connection with the Securities distributed by it. No person guilty of
fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The remedies provided for in this Section 8
are not exclusive and shall not limit any rights or remedies, which may otherwise be available to any indemnified party at law or in equity. 
 (f) The indemnity and contribution provisions contained in this Section 8 and the representations, warranties and other statements of the Company contained in this Agreement shall remain operative
and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation made by or on behalf of any Placement Agent, any person controlling any Placement Agent or any affiliate of any Placement Agent or by
or on behalf of the Company, its officers or directors or any person controlling the Company and (iii) acceptance of and payment for any of the Securities. 
 9. Termination. The Placement Agents may terminate this Agreement by notice given by you to the Company, if after the execution and delivery of this Agreement and prior to the Closing Date
(i) trading generally shall have been suspended or materially limited on, or by, as the case may be, any of the New York Stock Exchange, the American Stock Exchange, the Nasdaq Global Market, the Chicago Board of Options Exchange, the Chicago
Mercantile Exchange, the Chicago Board of Trade, or Bolsa Mexicana de Valores, S.A. de C.V., (ii) trading of any securities of the Company or KCS shall have been suspended on any exchange or in any over-the-counter market, (iii) a
material disruption in securities settlement, payment or clearance services in the United States or Mexico shall have occurred, (iv) any moratorium on commercial banking activities shall have been declared by Federal or New York State or
Mexican authorities or (v) there shall have occurred any outbreak or escalation of hostilities, or any change in financial markets, currency exchange rates or controls or any calamity or crisis that, in your judgment, is material and adverse
and which, singly or together with any other event specified in this clause (v), makes it, in your judgment, impracticable or inadvisable to proceed with the offer, sale or delivery of the Securities on the terms and in the manner contemplated in
the Time of Sale Memorandum or the Final Memorandum. 

  
 24 

 10. Effectiveness; Defaulting Placement Agents. (a) This Agreement shall become
effective upon the execution and delivery hereof by the parties hereto. 
 (b) If, on the Closing Date, any one or more of the
Placement Agents shall fail or refuse to purchase Securities that it or they have agreed to purchase hereunder on such date, and the aggregate principal amount of Securities which such defaulting Placement Agent or Placement Agents agreed but failed
or refused to purchase is not more than one-tenth of the aggregate principal amount of Securities to be purchased on such date, the other Placement Agents shall be obligated severally in the proportions that the principal amount of Securities set
forth opposite their respective names in Schedule I bears to the aggregate principal amount of Securities set forth opposite the names of all such non-defaulting Placement Agents, or in such other proportions as you may specify, to purchase the
Securities which such defaulting Placement Agent or Placement Agents agreed but failed or refused to purchase on such date; provided that in no event shall the principal amount of Securities that any Placement Agent has agreed to purchase
pursuant to this Agreement be increased pursuant to this Section 10 by an amount in excess of one-ninth of such principal amount of Securities without the written consent of such Placement Agent. If, on the Closing Date any Placement Agent or
Placement Agents shall fail or refuse to purchase Securities which it or they have agreed to purchase hereunder on such date and the aggregate principal amount of Securities with respect to which such default occurs is more than one-tenth of the
aggregate principal amount of Securities to be purchased on such date, and arrangements satisfactory to you and the Company for the purchase of such Securities are not made within 36 hours after such default, this Agreement shall terminate without
liability on the part of any non-defaulting Placement Agent or of the Company. In any such case either you or the Company shall have the right to postpone the Closing Date, but in no event for longer than seven days, in order that the required
changes, if any, in the Time of Sale Memorandum or the Final Memorandum or in any other documents or arrangements may be effected. Any action taken under this paragraph shall not relieve any defaulting Placement Agent from liability in respect of
any default of such Placement Agent under this Agreement. 
 (c) If this Agreement shall be terminated by the Placement Agents,
or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable to perform its obligations under this
Agreement, the Company will reimburse the Placement Agents or such Placement Agents as have so terminated this Agreement with respect to themselves, severally, for all out-of-pocket expenses (including the fees and disbursements of their counsel)
reasonably incurred by such Placement Agents in connection with this Agreement or the offering contemplated hereunder. 

  
 25 

 11. Entire Agreement. This Agreement, together with any contemporaneous written
agreements and any prior written agreements (to the extent not superseded by this Agreement) that relate to the offering of the Securities, represents the entire agreement between the Company and the Placement Agents with respect to the preparation
of the Time of Sale Memorandum, either Memorandum, the conduct of the offering, and the purchase and sale of the Securities. 

12. No Fiduciary Duties. The Company acknowledges and agrees that the Placement Agents are acting solely in the capacity of an
arm’s length contractual counterparty to the Company with respect to the Offer (including in connection with determining the terms of the Offer) and not as financial advisors or as fiduciaries to, or agents of, the Company or any other person.
Additionally, the Placement Agents are not advising the Company or any other person as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and
shall be responsible for making its own independent investigation and appraisal of the transactions contemplated hereby, and the Placement Agents shall have no responsibility or liability to the Company with respect thereto. Any review by the
Placement Agents of the Company, the transactions contemplated hereby or other matters relating to such transactions will be performed solely for the benefit of the Placement Agents and shall not be on behalf of the Company. 

13. Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be an original, with the same
effect as if the signatures thereto and hereto were upon the same instrument. 
 14. Consent to Jurisdiction. Appointment of
Agent to Accept Service of Process. 
 (a) Each of the Placement Agents and the Company irrevocably consents and agrees that
any legal action, suit or proceeding against it with respect to is obligations, liabilities or any other matter arising out of or based on this Agreement may be brought in any United States federal or state court in the State of New York, County of
New York, Borough of Manhattan. Each of the parties irrevocably and unconditionally waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of venue of any of the aforesaid actions, suits or
proceedings arising out of or in connection with this Agreement, the Registration Rights Agreement, the Indenture and the Securities brought in the federal courts located in the City of New York or the courts of the State of New York located in the
County of New York and hereby further irrevocably and unconditionally waives and agrees, to the fullest extent permitted by law, not to plead or claim in any such court that any such action, suit or proceeding brought in any such court has been
brought in an inconvenient forum, hereby waiving the venue of any other court to which they may have a right based on their domicile or otherwise. 

  
 26 

 (b) The Company designates, appoints, and empowers CT Corporation, with offices currently at
111 Eight Avenue, New York, New York 10011, as its designee, appointee and agent to receive and forward for and on its behalf, service of any and all legal process, summons, notices and documents that may be served in any action, suit or proceeding
brought against any of the liabilities or any other matter arising out of or in connection with this Agreement, the Registration Rights Agreement, the Indenture and the Securities that may be on such designee, appointee and agent in accordance with
legal procedures prescribed for such courts. If for any reason such designee, appointee and agent hereunder shall cease to be available to act as such, the Company agrees to designate a new designee, appointee and agent in The City of New York on
the terms and for the purposes of this Section 14 reasonably satisfactory to the Placement Agents. The Company further hereby irrevocably consents and agrees to the service of any legal process, summons, notices and documents in any such
action, suit or proceeding against the Company by serving a copy thereof upon the relevant agent of service of process referred to in this Section 14 (whether or not the appointment of such agent shall for any reason prove to be ineffective or
such agent shall accept or acknowledge such service). The Company agrees that the failure of any such designee, appointee and agent to give any notice of such service to them shall not impair or affect in any way the validity of such service or any
judgment rendered in any action or proceeding based thereon. Nothing herein shall in any way be deemed to limit the ability of the Placement Agents to serve any such legal process, summons, notices and documents in any other manner permitted by
applicable law or to obtain jurisdiction over the Company or bring actions, suits or proceedings against them in such other jurisdictions, and in such manner, as may be permitted by applicable law. 

15. Judgment Currency. If for the purposes of obtaining judgment in any court it is necessary to convert a sum due hereunder into
any currency other than U.S. dollars, the parties hereto agree, to the fullest extent that they may effectively do so, that the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Placement Agents could
purchase U.S. dollars with such other currency in The City of New York on the business day preceding that on which final judgment is given. The obligations of the Company in respect of any sum due from it to any Placement Agent shall,
notwithstanding any judgment in any currency other than U.S. dollars, not be discharged until the first business day, following receipt by such Placement Agent of any sum adjudged to be so due in such other currency, on which (and only to the extent
that) such Placement Agent may in accordance with normal banking procedures purchase U.S. dollars with such other currency; if the U.S. dollars so purchased are less than the sum originally due to such Placement Agent hereunder, the Company agrees,
as a separate obligation and notwithstanding any 

  
 27 

 
such judgment, to indemnify such Placement Agent against such loss. If the U.S. dollars so purchased are greater than the sum originally due to such Placement Agent hereunder, such Placement
Agent agrees to pay to the Company an amount equal to the excess of the U.S. dollars so purchased over the sum originally due to such Placement Agent hereunder. 
 16. Applicable Law. This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York. 

17. Headings. The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be
deemed a part of this Agreement. 
 18. Notices. All communications hereunder shall be in writing and effective only upon
receipt and if to the Placement Agents shall be delivered, mailed or sent to Merrill Lynch, Pierce, Fenner & Smith Incorporated, One Bryant Park, New York, New York 10036, Attention: High Yield Capital Markets Syndicate Desk; and if to
the Company shall be delivered, mailed or sent to Kansas City Southern de México, S.A. de C.V., Montes Urales No. 625, Col. Lomas de Chapultepec, Delegación Miguel Hidalgo, 11000, México D.F., Attention: Chief Financial
Officer. 

  
 28 

  

			
	Very truly yours,
	
	 KANSAS CITY SOUTHERN de MÉXICO,
S.A. de C.V.

		
	By:	 	 /s/ Paul J. Weyandt

		 	Name: Paul J. Weyandt
		 	Title: Treasurer and Attorney-in-fact

  

					
	 Accepted as of the date hereof
  

Merrill Lynch, Pierce, Fenner & Smith

		 	Incorporated	 	
	
	Acting severally on behalf of themselves and the several Placement Agents named in Schedule I
hereto.

  

			
	By:	 	Merrill Lynch, Pierce, Fenner &
Smith
                      Incorporated
		
	By:	 	 /s/ Pei-Tse Wu

		 	Name: Pei-Tse Wu
		 	Title: Managing Director

 [PLACEMENT
AGREEMENT] 

 SCHEDULE I 

 

					
	 Placement Agent
	  	Principal amount of
Securities to be Purchased	 
		
	 Merrill Lynch, Pierce, Fenner & Smith

                   
   Incorporated
	  	$	92,500,000	  
	 J.P. Morgan Securities LLC
	  	 	46,250,000	  
		  	 	 	 
	 Scotia Capital (USA) Inc.
	  	 	24,050,000	  
		  	 	 	 
	 BBVA Securities Inc.
	  	 	7,400,000	  
		  	 	 	 
	 Citigroup Global Markets Inc
	  	 	7,400,000	  
		  	 	 	 
	 UBS Securities LLC
	  	 	7,400,000	  
		  	 	 	 
	 Total:
	  	$	185,000,000	  
		  	 	 	 

 SCHEDULE II 

 

					
	PRICING SUPPLEMENT	  		  	STRICTLY CONFIDENTIAL
		  	$185,000,000	  	
			
		  	

	  	

 KANSAS CITY SOUTHERN DE MÉXICO, S.A. DE C.V. 

6.625% Senior Notes due 2020 
 December 14, 2010 
  
 This Pricing Supplement is qualified in its entirety by reference to the Preliminary Offering Memorandum dated December 14, 2010 (the “Preliminary Offering Memorandum”). The information in
this Pricing Supplement supplements the Preliminary Offering Memorandum and supersedes the information in the Preliminary Offering Memorandum to the extent this information is inconsistent with the information in the Preliminary Offering Memorandum.
Capitalized terms used in this Pricing Supplement but not defined have the meanings given to them in the Preliminary Offering Memorandum. 

The Notes (as defined below) have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and may not be
offered or sold, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. Accordingly, the Notes are being offered and sold (1) only to “qualified institutional
buyers” (as defined in Rule 144A under the Securities Act) and (2) outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act. 
 The Notes have not been and will not be registered with the Mexican National Securities Registry (Registro Nacional de Valores) maintained by the Mexican National Banking and Securities Commission
(Comisión Nacional Bancaria y de Valores) and may not be offered or sold publicly, or otherwise be the subject of broker activities in Mexico, except pursuant to a private placement exemption set forth under Article 8 of the Mexican
Securities Market Law (Ley del Mercado de Valores). 
  

			
	Issuer:	  	Kansas City Southern de México, S.A. de C.V.
		
	Aggregate Principal Amount:	  	$185,000,000
		
	Title of Securities:	  	6.625% Senior Notes due 2020 (the “Notes”)
		
	Final Maturity Date:	  	December 15, 2020
		
	Issue Price:	  	100.000% plus accrued interest from December 20, 2010.
		
	Coupon	  	6.625%
		
	Yield to Maturity	  	6.625%
		
	Gross Proceeds	  	$185,000,000 before placement agents’ discounts and estimated offering expenses.
		
	Interest Payment Dates:	  	December 15 and June 15
		
	Record Dates:	  	December 1 and June 1
		
	First Interest Payment Date:	  	June 15, 2011

							
	Optional Redemption:	 	 On or after December 15, 2015, the Company may, at its option, redeem the Notes in whole at any time or in part from
time to time, upon not less than 30 nor more than 60 days’ notice, at the following redemption prices (expressed as percentages of the principal amount thereof) if redeemed during the 12-month period commencing on December 15 of the year
set forth below, plus, in each case, accrued interest, liquidated damages, if any, and any Additional Amounts to the date of redemption:
	        

			
	 	 	 Year
	  	 Percentage
	 
		 	 2015
	  	 	103.313%	  
		 	 2016
	  	 	102.208%	  
		 	 2017
	  	 	101.104%	  
		 	 2018 and thereafter
	  	 	100.000%	  
		
	Optional Redemption with Equity Proceeds:	 	At any time prior to December 15, 2013, the Company may redeem up to 35% of the principal amount of the Notes issued under the Indenture at a redemption price of
106.625% of their principal amount, plus accrued interest and liquidated damages, if any, and any Additional Amounts to the redemption date, with the Net Cash Proceeds of one or more Equity Offerings by KCSM or KCS, to the extent the Net Cash
Proceeds thereof are contributed to KCSM or used to purchase Capital Stock (other than Disqualified Stock) of KCSM from KCSM; provided, that: (1) at least 65% of the original aggregate principal amount of Notes issued under the Indenture remains
outstanding after giving effect to any such redemption; and (2) the redemption occurs within 90 days of the date of the closing of such Equity Offering and is made in accordance with certain procedures set forth in the Indenture.	           
		
	Additional Optional Redemption:	 	At any time prior to December 15, 2015, the Company may redeem all or a part of the notes, upon not less than 30 nor more than 60 days’ prior notice mailed by
first-class mail to each holder’s registered address, at a redemption price equal to 100% of the principal amount of notes redeemed plus the Applicable Premium as of, and accrued and unpaid interest if any, to the date of redemption, subject to
the rights of holders of notes on the relevant record date to receive interest due on the relevant interest payment date.	       
		
		 	Upon completion of the registered exchange offer as described under “Description of the Notes—Registered Exchange Offer; Registration Rights,” the Company
may also redeem any Notes which were not exchanged in the registered exchange offer in an amount up to 2% of the original aggregate principal amount of Notes issued at a redemption price of 100% of their principal amount plus accrued interest,
liquidated damages, if any, and any Additional Amounts to the redemption date.	       
		
		 	In addition, the Company may, at its option, redeem the Notes, in whole but not in part, at any time at a redemption price of 100% of their principal amount plus accrued
interest, liquidated damages, if any, and any Additional Amounts to the redemption date if the Mexican withholding tax rate on payments of interest in respect of the Notes is increased, as a result of a change in Mexican law, to a rate in excess of
4.9%.	      

					
	 Placement Agents:
	 	 Merrill Lynch, Pierce, Fenner & Smith
                       Incorporated
 J.P. Morgan Securities LLC
 Scotia Capital (USA) Inc.

BBVA Securities Inc.
 Citigroup Global Markets
Inc.
 UBS Securities LLC

		
	Trade Date:	 	December 14, 2010
		
	Settlement Date:	 	December 20, 2010 (T+4 business days)
		
	144A CUSIP/ISIN Numbers:	 	485161 AJ2/US485161AJ23
		
	Reg S CUSIP/ISIN Numbers:	 	P6052A AE4 /USP6052AAE49

 SCHEDULE III 
 Supplemental Marketing Materials 
 Investor Presentation, dated
December 14, 2010

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00182-of-00352.parquet"}]]